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ABSTRACT 
 
Cognitive impairment in Parkinson’s disease (PD) can impact negatively on caregivers and is 
associated with carer distress and feelings of burden. To investigate this relationship we examined 
level of burden, coping strategies, depression, anxiety and potential positive aspects of caregiving in 
the caregivers of 104 PD patients. The PD patients were classified as either showing normal cognition 
(PD-N; n=57), with mild cognitive impairment (PD-MCI; n=31) or with dementia (PD-D; n=16). The 
key finding was that mean Zarit burden score increased between carers of PD-N (M=14.1, SD=12.0) 
through to PD-MCI (M=21.1, SD=9.86) and PD-D (M=27.8, SD=10.61); F (2,101) =9.96, p<0.001. 
Post hoc tests (Newman-Keuls) identified significantly higher Zarit burden scores in PD-D caregivers 
compared to both PD-N (p<.001) and PD-MCI patients (p<.05), but carers of PD-MCI patients also 
showed increased burden scores relative to those of PD-N patients (p<.05). The proportion of carers 
showing significant levels of burden (Zarit burden score ≥21) also increased as cognition declined 
(21% for PD-N; 58% for PD-MCI; and 81% for PD-D). Time spent providing care and problem-
focused, emotion-focused and dysfunctional coping strategies also increased with worsening 
cognition. While caregiver use of problem-focused coping mediated the association between patient 
cognitive status and caregiver burden, we could not be confident about this relationship as the inverse 
model was also significant. Caregiver Zarit burden was independent of caregiver depression, anxiety 
and positive attributions of caregiving. The study highlights the impact of Parkinson’s disease on those 
providing care when the patients’ cognition is poor, including those with MCI. Caregiver well-being 
has important implications for nursing home placement and disease course.  
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1 INTRODUCTION.  
Parkinson’s disease (PD) is a motor disorder in which cognitive and behavioural sequelae are now 
better recognized as having a significant impact on patient well-being (Janvin, Aarsland, & Larsen, 
2005). Cognitive decline in PD is also likely to impact on caregivers but this important facet of the 
disorder is less well documented. Recently, published criteria characterise PD cognition into 3 levels 
of cognitive status, those patients with relatively normal cognition (PD-N), those with mild cognitive 
impairment (PD-MCI) and those with dementia (PD-D) (Emre et al., 2007; Litvan et al., 2012). This 
new perspective underscores the need to investigate the influence of these different levels of cognitive 
status on caregiver outcome in PD. Dementia is expected to be associated with increased burden for 
caregivers of PD patients (Leroi, McDonald, Pantula, & Harbishettar, 2012; Thommessen et al., 2002), 
but mild cognitive impairment and neurobehavioural symptoms may also generate increased risk of 
negative outcomes for caregivers beyond that associated with the motor disorder that characterises PD. 
The following section outlines current perspectives on cognition in PD. The subsequent section 
describes caregiving in general terms as well as in the PD context. An overview of other factors that 
influence outcomes for PD caregivers is then provided. The chapter concludes with a brief summary of 
the rationale for the current study.  
1.1 Cognition in Parkinson’s disease. 
Parkinson’s disease is a complex motor disorder that is clinically manifest when dopaminergic cell 
depletion in the substantia nigra leads to the cardinal motor symptoms of PD (Braak et al., 2003). 
Cognitive and behavioural symptoms in PD relate to deficiencies in serotonergic, noradrenergic and 
cholinergic neurotransmission, in addition to dopaminergic decline, and neuropathological changes 
across many brain systems (Braak et al., 2003; Jellinger, 2012). Symptomology is often variable and 
often unpredictable, although an influential perspective is that changes broadly often follow a 
predictable pattern (Beach et al., 2009; Braak et al., 2003). The unfolding complexity of this disease 
process makes PD caregiving uniquely challenging for patients and caregivers (Hooker, Manoogian-
O'Dell, Monahan, Frazier, & Shifren, 2000). 
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Cognitive difficulties in PD may occur at varying stages of the disease. These deficits span any 
of the core cognitive domains of attention, visuospatial function, executive function and memory. 
Progressive worsening of cognitive function may eventually impact a patient’s ability to carry out 
activities of daily living and thus result in dementia (Dubois et al., 2007). Age of PD onset, duration of 
disease, long term use of medication, severity of motor symptoms and a low prodromal level of 
cognitive functioning are often cited as risk factors for major cognitive decline (Bosboom, Stoffers, & 
Wolters, 2004). Dementia is common among patients with an average incidence of 30-40 % in cross-
sectional studies (Emre et al., 2007) and a cumulative prevalence of 75%-90% (Hely, Reid, Adena, 
Halliday, & Morris, 2008). Thus cognitive decline is a factor that will impact nearly all PD patients 
and their carers.  
With increased awareness of the high probability of future dementia is a growing interest in the 
identification and description of PD patients with mild cognitive impairment (PD-MCI), which carries 
an increased probability of future dementia (Pedersen, Larsen, Tysnes, & Alves, 2013). Until recently 
a description of PD-MCI has been lacking but has relevance to our understanding of the effect of 
cognitive decline. PD-MCI status may provide a well-characterized patient population for examining 
outcome measures for clinical trials and a useful clinical entity to enable patients, caregivers, 
clinicians and researchers to improve care and research efforts (Litvan et al., 2012). 
Recently published guidelines by the Movement Disorders (MDS) Task Force describe 
inclusion/exclusion criteria for PD–MCI (Litvan et al., 2012). Two levels of assessment have been 
suggested depending on the need for clinical characterisation and diagnostic certainty. Both levels 
require cognitive decline in the context of established PD with impairments not interfering 
significantly with functional independence. Level I consists of a brief assessment demonstrating 
impairment on global cognitive tests or impairment on 1 or 2 tests in less than 5 different cognitive 
domains. The more comprehensive Level II assessment requires assessment of at least 2 tests within 
each of the 5 cognitive domains of attention and working memory, executive function, language, 
memory and visuospatial function. Impairment is required on at least 2 neuropsychological tests in 1 
or 2 of these cognitive domains, although the level of impairment is not fixed and allowed to span 
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anywhere from 1 to 2 standard deviations below normative data, pending researchers’ preferences and 
taking into account estimated levels of premorbid functioning.  
Inclusion criteria for probable PD-D are the development of dementia within the context of 
established PD, shown by impairment in at least 2 cognitive domains that coexist with and are deemed 
responsible for impaired activities of daily living (ie. loss of functional independence not due to motor 
complications). The presence of at least one behavioural symptom supports the diagnosis of probable 
PD-D but a lack of behavioural symptoms does not exclude it. Possible PD-D differs from probable 
PD-D in that, atypical cognitive impairments are present with the co-existence of other abnormalities 
that may instead cause cognitive impairment. When the time interval between the development of 
motor symptoms and significant loss of everyday functional independence is unknown a diagnosis of 
possible PD-D is also preferable to probable PD-D unless a diagnosis of Dementia with Lewy Bodies 
is more likely (McKeith & Mosimann, 2004). 
1.2 Caregiving in Parkinson’s disease. 
Ageing populations are creating an increased demand for health care services and an increase in the 
incidence of age-related neurodegenerative disorders (Cornwall & Davey, 2004). Along with the rise 
in caregiver numbers is an appreciation of the increased strain and distress that can accompany care 
provision. The term ‘the hidden patient’ was coined in 1979 to describe the spouses of disabled elderly 
men, to emphasize the negative impact of caregiving (Fengler & Goodrich, 1979). In New Zealand 
caregiving is common and saves the formal health care system millions of dollars annually. Caregivers 
are predominantly female and middle aged (Goodhead & McDonald, 2007). Influences on caregivers 
depend on the nature and stage of the illness or injury; progressive diseases such as PD may create 
escalating dependency and distress on caregivers. Caregiving research has become the focus of clinical 
studies to improve knowledge of the determinants of caregiver outcomes and as an outcome variable 
for the pharmaceutical industry to evaluate the effects of new drug therapies for patients (Carter, 
Stewart, Lyons, & Archbold, 2008; Goodhead & McDonald, 2007).  
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In the last two decades over 400 empirical studies on the psychological effects of caregiving 
have been published but few have investigated PD caregiving (Pinquart & Sorensen, 2003). The 
heterogeneous nature, prognosis, and progression of PD as well as the beneficial effect of 
interventions, underscore the need for factors leading to caregiver distress to be clearly identified and 
described. The wider caregiving literature has seen a recent trend to consider not only relevant patient 
and caregiver characteristics, but also the mechanisms determining outcomes (Pinquart & Sorensen, 
2003). Additionally, the newly identified clinical entity of PD-MCI has relevance for caregivers, as 
problems appearing early have long-term implications for caregivers’ outcomes such as burden and 
depression (Blieszner & Roberto, 2010). The characterisation of PD-MCI has been described as a 
“crucial and unmet need for the overall care of PD patients” (Litvan et al., 2012). 
Parkinson’s Disease Cognition and Caregiving. 
To the best of our knowledge, 11 studies and one meta-analysis (Lau & Au, 2011) have investigated 
the impact of cognition on PD caregivers but the results were contradictory (Table 1-1). Six studies 
reported a significant relationship between PD patient cognitive status and negative caregiver outcome 
and 5 studies found no association. The meta-analysis reported a significant association between PD 
patient cognition and negative caregiver outcomes and this is discussed in detail later. The studies 
included in the meta-analysis are indicated in Table 1-1.  
Some investigators used only mental status tests. Three studies found a significant association 
between the Mini-Mental State Exam (MMSE) and negative caregiver outcome (Aarsland, Larsen, 
Karlsen, Lim, & Tandberg, 1999; Cifu et al., 2006; Martinez-Martin et al., 2008; Thommessen et al., 
2002) while two studies found no association (D'Amelio et al., 2009; Fernandez, Tabamo, David, & 
Friedman, 2001). However the MMSE is only a screening instrument (Nasreddine et al., 2005) and its 
use has led to some debate because of floor and ceiling effects which may fail to identify patients with 
early dementia (Nieuwenhuis-Mark, 2010). Others employed instruments to identify impairment 
across cognitive domains although in the main these were limited to tests in 1 or 2 domains (Carter, 
Stewart, Lyons, & Archbold, 2008; Miller, Berrios, & Politynska, 1996). The current Movement 
Disorders Society Task Force guidelines require more thorough assessment to establish cognitive 
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status and highlight the importance of PD-MCI as a clinical entity (Litvan et al., 2012). Dementia 
ratings were provided in two studies; one reported that there was no association between Dementia 
Rating Scale (DRS) score and Zarit burden (Cifu et al., 2006) and in the other dementia status was 
associated with but not predictive of caregiver stress (Aarsland, Larsen, Karlsen, Lim, & Tandberg, 
1999). In terms of describing caregiver outcomes, the Zarit Burden Interview (ZBI) remains the most 
widely used instrument in the general caregiving literature, but this instrument has been used 
infrequently in PD caregiving studies (Table 1-1). All three studies using the ZBI reported significant 
associations with cognitive impairment (Cifu et al., 2006; Leroi, McDonald, Pantula, & Harbishettar, 
2012; Martinez-Martin et al., 2008). 
The significant but complex relationship between PD patient cognitive status and negative 
caregiver outcomes has been highlighted in several studies. Aarsland et al. (1999) and Martinez-
Martin et al. (2007) investigated the impact of patient cognition, neuropsychiatric and motor 
symptoms on caregivers and found significant associations between these variables and negative 
caregiver outcomes. Only the study by Aarsland et al. (1999) included PD-D patients. Both 
investigations reported that cognitive impairment and neuropsychiatric symptoms were the strongest 
predictors of negative caregiver outcome (Table 1-1). The multiple regression techniques employed in 
these studies highlight that while cognition is an important factor, neuropsychiatric symptoms are also 
noteworthy. Carter and colleagues (2008) used caregiver depression as the outcome variable in 
multiple regression and found that while motor symptoms made a modest contribution, PD patients’ 
abilities in delayed recall was the strongest predictor in the model. Thommessen and colleagues (2002) 
compared outcomes for caregivers of dementia, stroke and PD patients (none of whom had PD-D). It 
was reported that cognition and depression were the strongest predictors of psychosocial burden in all 
3 groups. The authors also found that mean Mini Mental State Exam (MMSE) scores for the non-PD 
dementia patients were significantly lower than PD patients but that PD caregivers experienced more 
burden. This finding highlights the increased burden among PD caregivers in addition to cognition.  
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Table 1-1. Studies including PD patient cognition in determinants of caregiver outcome.  
* Adapted from Lau & Au, 2011. 
ABS Affect Balance Scale; ADL-IS Activities of Daily Living; BDI Beck Depression Inventory; BLO Benton Line Orientation 
test; CAMCOG Cambridge Cognitive Examination; CBI Caregiver Burden Inventory; CDS (NPI) Caregiver Distress Scale of 
Neuropsychiatric Inventory; CES-D Centre of Epidemiological Studies Depression scale; CIRS-G Cumulative Illness Rating 
Scale-Geriatrics; CSI Caregiver Strain Inventory; DCFS Dementia Cognitive Fluctuations Scale; DRS Dementia Rating Scale; 
EuroQoL European scale of Health-related Quality of Life; HADS Hospital Anxiety and Depression Scale; HAMD-17 Hamilton 
Depression Scale; HDRS Hamilton Depression Rating Scale; H&Y Hoehn & Yahr; GDS Geriatric Depression Scale; GHQ 
General Health Questionnaire; ISAPD-ADL Intermediate Scale for Assessment of Parkinson’s disease; KPSS Karnofsky 
Performance Status Scale; MADRS Montgomery-Asberg Depression Rating Scale; MMSE Mini-Mental State Exam;MSS 
Machin Strain Scale; NPI Neuropsychiatric Inventory; NWS North Western Scale; PDQ Patient Functional Status; PPRS 
Parkinson’s disease Psychosis Rating Scale; RDRS-2 Rapid Disability Rating Scale. RSS Relatives’ Stress Scale; SCOPA-Cog, 
motor, sleep, Aut and PS  Scales for outcomes in Parkinson’s disease-Cognition, motor , sleep, Autonomic, Psychosocial; S&E 
ADL Swab & England Activities of Daily Living; SF-12v2 Short Form Health Survey version 2; SF-36 Short Form Health 
Survey; SOC Sense of Coherence; SQLC Scale of Quality of Life of Caregivers; SSSQ Short Social Support Questionnaire; 
UPDRS-ADL Unified Parkinson’s Disease Rating Scale-Activities of Daily Living; UPDRS Unified Parkinson’s Disease Rating 
Scale Parts I-IV; VAS visual analogue scale for pain; Webster Rating Scale; WHO scale Measure of disability; ZBI Zarit Burden 
Interview; *NP Neuropsychological testing following Movement Disorders guidelines, level I criteria. 
 
 
Authors PD Patient Cog 
Status  
PD patient assessment  
tools 
Measures of 
 CG distress 
Correlates/Predictors of negative outcomes for 
caregivers 
*Aarsland et al., 
1999 
(n=94) 
20 PD-D MMSE, UPDRS-II and III, 
S&E, DRS, H&Y, ADL, NPI, 
MADRS, BDI 
RSS, BDI,  
GHQ 
Cognitive impairment and neuropsychiatric 
symptoms predicted CG poor health  
Cognitive impairment and patient depression 
predicted CG social distress Patient depression 
and neuropsychiatric symptoms predicted CG 
depression  
*Carter et al., 2008 
(n=219) 
Not given 
(Early or middle 
stage) 
Delayed recall; UPDRS –III 
& ADL, , HDRS 
Family Care 
Inventory,  
CES-D 
Cognitive impairment 
Depression 
*Cifu et al., 2006 
(n=49) 
Not given (Only 
80% with PD) 
MMSE, DRS-2, UPDRS I-
IV,Pain VAS, H&Y, S&E 
ADL 
ZBI, Caregiver 
survey 
CDS (NPI) 
Cognitive impairment, sleep problems, 
difficulties with activities of daily living and 
motor symptoms  
D’Amelio et al., 
2009 (n=)=40 
5 PD-D MMSE, UPDRS II and III 
H&Y, NPI, GDS 
CBI and GDS PD patient disease severity 
Neuropsychiatric symptoms 
*Fernandez 2001 
(n=45) 
MMSE range = 
13-30 
MMSE, Neuropsychiatric Qs. 
UPDRS-III, H&Y, HAMD-
17,BDI-II 
HAMD-17,  
BDI-II 
Disease duration 
Patient depression 
Lee et al., 2012 
(n=32) 
32 PD-D CAMCOG, UPDRS II and III NPI CG distress 
scale, DCFS 
Cognitive fluctuations, subtype diagnosis, and 
neuropsychiatric symptoms 
Leroi et al., 2012 
(n=102) 
n=54(PD-N) 
n=48(PD-MCI) 
n=25(PD-D) 
NP tests* (MDS critera) 
PDQ-8, NPI, UPDRS-II, IV 
and ADL 
ZBI, NPI CG 
distress scale 
 
Cognitive status in PD-D patients only 
Martinez-Martin et 
al., 2008 (n=286) 
SCOPA-Cog 
range= 2-40 
SCOPA-Cog, H&Y, Motor, 
Sleep, Aut, and PS, HADS, 
PPRS, CISI-PD,PPRS, CIRS-
G, VAS, EuroQoL 
ZBI, HADS, 
EuroQoL  
Cognitive impairment 
Caregiver affective status  
*Meara et al., 1999 
(n=132) 
No severe 
dementia 
CAMCOG, GDS, Webster 
Rating Scale 
GDS Cognition (trend only) 
Disease severity 
*Miller et al.,1996 
(n=54) 
No given 
(disease 
duration ≥2 
years) 
Word reading, BLO, word 
recall, Webster Scale, NWS, 
H&Y, KPSS, WHO Scale 
GHQ, GDS, 
BDI, MSS 
Patient depression  
Motor symptoms  
Thommessen et al., 
2002 (n=58) 
Mean MMSE = 
26.2 
MMSE, MADRS, UPDRS-
ADL 
RSS Cognition 
Patient depression 
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The study by Leroi and colleagues (2012) is the only study that has reported on the impact of 
PD-N, PD-MCI and PD-D on caregiver burden since the Movement Disorders Society (MDS) Task 
Force guidelines were published. Correlation analyses for the entire group revealed significant 
associations between motor severity, duration of motor symptoms and Mini-Mental State Exam score 
with caregiver burden. The authors found that caregiver burden was similar in those caring for patients 
without dementia (PD-N and PD-MCI) but significantly greater for those caring for patients with PD-
D. The results were similar for PD patient quality of life measures with similar scores in those caring 
for patients without dementia (PD-N and PD-MCI) but significantly less for those caring for patients 
with PD-D. In terms of patient neuropsychiatric symptoms, no significant differences between the 
three groups were found. Leroi and colleagues (2012) established cognitive status with level I criteria 
which including eight neuropsychological tests in attention and working memory, executive function, 
memory and visuo-spatial function as well as the Mini-Mental State Exam (MMSE). In brief, PD-MCI 
was identified in patients with a MMSE score ≥ 26, cognitive deficits on at least two of the eight tests 
with deficits defined as at least 1.5 standard deviations below norms and cognitive deficits not severe 
enough to interfere with activities of daily living. PD-D status was established with MDS criteria, 
(Emre et al., 2007) including MMSE score < 26, deficits in more than one cognitive domain and 
functional impairment due to cognitive deficits. This neuropsychological assessment was insufficient 
to reach level II criteria and thus has less diagnostic certainty (Litvan et al., 2012) which may have led 
to some incorrect cognitive classification. 
Several other PD caregiving studies have provided evidence that factors other than cognition are 
also associated with negative caregiver outcomes. Relative to the Mini-Mental State Exam, one study 
reported that disease stage and neuropsychiatric symptoms more strongly predicted burden (D'Amelio 
et al., 2009) and another that disease duration predicted caregiver depression (Fernandez, Tabamo, 
David, & Friedman, 2001). Miller and colleagues (1996) found that cognitive test scores correlated 
with caregiver depression but only patient depression and physical functioning predicted caregiver 
distress in multiple regression analyses. Another early study used a more detailed cognitive assessment 
instrument, the Cambridge Cognitive Examination (CAMCOG), but only a trend towards association 
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with caregiver depression was found (Meara, Mitchelmore, & Hobson, 1999). Lee and colleagues 
(2012) also used the CAMCOG to assess patient cognition when they compared outcomes for 
caregivers of patients with different types of dementia; Dementia with Lewy Bodies, Alzheimer’s, 
vascular dementia and PD-D. The authors reported that type of dementia and cognitive fluctuation 
score were the significant predictors of caregiver stress.  
The meta-analysis describing the correlates of caregiver distress in PD examined 10 studies 
(Lau & Au, 2011). It was concluded that motor symptoms had the strongest relationship with 
caregiver burden and depression. While the size of the associations were greater for motor symptoms 
(r=.42), there was also a significant correlation for cognition (r=.28). At the time of publication of the 
meta-analysis (2011) there were 9 studies with cognition as a factor available for inclusion however 
the authors only reported on 6 studies (Table 1-1). Hence the impact of PD patient cognition on 
caregiver outcome is not clear and requires further investigation.  
In contrast to PD, the characterisation of MCI in Alzheimer’s individuals is well-established 
(Petersen, 2004) and reports of MCI caregivers are emerging (Bruce, McQuiggan, Williams, 
Westervelt, & Tremont, 2008; Garand, Dew, Eazor, DeKosky, & Reynolds, 2005). One recent study 
(Bruce, McQuiggan, Williams, Westervelt, & Tremont, 2008) reported that 30% of Alzheimer’s MCI 
caregivers demonstrated significant burden (Zarit burden score ≥ 21; Zarit, Reever, & Bach-Peterson, 
1980). This study included use of a comprehensive neuropsychological battery to ensure that no 
patients met the criteria for a dementia diagnosis, and thus demonstrated the presence of caregiver 
burden in Alzheimer’s MCI. An earlier smaller study (n = 27) of MCI patients reported that 
Alzheimer’s caregivers had rates of distress that were intermediate to those of otherwise healthy older 
adults and those seen in dementia caregivers (Garand, Dew, Eazor, DeKosky, & Reynolds, 2005). It 
may be expected therefore, that PD-MCI would also be associated with caregiver burden.  
Some researchers have excluded cognition from their investigations into PD caregiving and 
demonstrated that factors such as patient motor problems, neuropsychiatric symptoms and time spent 
caregiving also impact negatively on caregivers (Table 1-2). The results of these studies plus the 
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contradictory findings described in Table 1-1, suggest that cognition in combination with these other 
patient and caregiver variables may be associated with negative PD caregiver outcomes.  
The Influence of PD Patient Motor Symptoms.  
In their review of the treatment of behavioural symptoms and dementia in Parkinson's disease 
Hanagasi and Emre (2005) stated that these two symptoms are often more disabling than motor 
dysfunction. This view may hold for caregivers also although the results of studies investigating the 
impact of motor symptoms in PD are inconclusive (Table 1-1 and Table 1-2). In some studies 
significant associations between motor symptoms and negative caregiving outcomes became non-
significant in multivariate analyses when cognitive and neurobehavioural symptoms are included, as 
described previously (Aarsland, Larsen, Karlsen, Lim, & Tandberg, 1999; Carter, Stewart, Lyons, & 
Archbold, 2008; Miller, Berrios, & Politynska, 1996). However a large study (n = 626) by Peters and 
colleagues (2011), used the Parkinson’s Disease Questionnaire-39 (PD-Q-39) instrument which covers 
eight aspects of patient quality of life including cognition and concluded that patient limitations in 
physical mobility as well as caregiver problems with social support were strongly associated with 
caregiver strain. Schrag and colleagues (2006) also demonstrated a significant association between 
patient falls and caregiver burden although the incidence of falls and the presence of motor symptoms 
came from patient self-report which can be unreliable (MacKenzie, Byles, & D'Este, 2006). 
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Table 1-2. PD Caregiving studies not including patient cognition as a determinant of caregiver outcome.  
CGI-S Clinical Global Impression-Severity scale; EuroQoL European scale of Health-related Quality of Life; HADS Hospital 
Anxiety and Depression Scale; H&Y Hoehn & Yahr; GDS Geriatric Depression Scale; GHQ General Health Questionnaire; 
Health SF-12v2 Health Short Form 12 version 2; NPI Neuropsychiatric Inventory; NWS North Western Scale; PDQ-39 Patient 
Functional Status; SOC Sense of Coherence; UPDRS-ADL Unified Parkinson’s Disease Rating Scale-Activities of Daily Living; 
UPDRS Unified Parkinson’s Disease Rating Scale Parts I-IV; ZBI Zarit Burden Interview.  
 
The Influence of Neuropsychiatric Symptoms in PD patients. 
Various neurobehavioural symptoms are common in PD and are associated with caregiver distress 
(Aarsland et al., 2007; Lee, McKeith, Mosimann, Ghosh-Nodyal, & Thomas, 2012). The range of 
symptoms includes delusions, hallucinations, agitation/aggression, depression, anxiety, euphoria, 
apathy, disinhibition, irritability/lability, aberrant motor behaviour, sleep disturbances and appetite 
disturbances. They are usually quantified in terms of frequency and severity from caregiver reports; 
the Neuropsychiatric Inventory (NPI) is the most commonly used instrument for this purpose 
(Cummings et al., 1994). A large meta-analysis of 228 studies in the general caregiving literature 
reported that, of 6 caregiving-related variables (physical impairments, cognitive impairments, problem 
behaviour, hours of care, number of caregiving tasks and number of months in the caregiving role), 
care recipient’s problem behaviour displayed the strongest association with caregiver burden and 
depression (Pinquart & Sorensen, 2003). 
A large multicentre study provided a comprehensive description of the impact of 
neuropsychiatric symptoms in PD-D patients on caregiver distress (Aarsland et al., 2007) (Table 1-2). 
Author/s PD patient assessment 
tools 
Measures of CG 
burden/distress 
Significant associations with negative 
caregiver outcomes  
Aarsland et al., 
2007 (n=537) 
UPDRS-III, NPI, H&Y  Distress scale of NPI Delusions, apathy, aggression, 
depression and irritability 
Caap-Ahlgren et 
al.,  2001(n=67) 
H&Y, Health PDQ-39 ZBI, SOC, GDS, social 
support 
H&Y 
 
Carter et al., 1998 
(n=380) 
H&Y Family Caregiving 
Inventory 
H&Y 
 
Leiknes etal., 
2010 
(n=189) 
NPI, UPDRS-
ADL&III, H&Y 
NPI distress scale  Apathy and depression  
H&Y 
 
Martinez-Martin 
et al., 2007 
(n=80) 
SMS-ADL, H&Y, BI, 
CGI-S, HADS, 
EuroQOL, Hours spent 
caring 
ZBI, HADS, SF-36, 
EuroQoL 
H&Y, ADL BI, Scopa-II 
Mood HADS 
Hours of care 
Peters et al., 2011 
(n=626) 
HealthSF-12v2, PDQ-
39 
SF-12v2 and CSI PDQ-39 mobility,  
Social support 
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Delusions, apathy, agitation, depression and irritability were associated with the highest distress 
scores, with moderate distress (Caregiver Distress Scale of the Neuropsychiatric Inventory ≥3; 
Cummings et al., 1994) reported by > 20% caregivers. Additionally, agitation was significantly 
associated with low Mini-Mental State Exam scores which reflects a relationship between 
neuropsychiatric symptoms and cognition.  
Even newly diagnosed PD is associated with caregiver distress. One study compared 
Neuropsychiatric Inventory caregiver distress scores with those from a control group comprised of 
healthy individuals and their next of kin who provided information regarding patient’s/control’s 
neurobehaviour (Leiknes, Tysnes, Aarsland, & Larsen, 2010). Nearly 50% of the PD caregivers 
reported distress and more than 25% reported moderate distress (Caregiver Distress Scale of the 
Neuropsychiatric Inventory ≥3). Next of kin of patients with PD reported 3 times more burden in 
association with neuropsychiatric symptoms than those in the control group. Symptoms of apathy, 
depression, anxiety and irritability symptoms being the most troublesome.  
Caregiver Depression and Anxiety. 
Depression and anxiety measures in caregivers have been frequently used in caregiving studies as 
proxy markers for distress (Lee, McKeith, Mosimann, Ghosh-Nodyal, & Thomas, 2012; Pinquart & 
Sorensen, 2003). Most research examining depression in caregivers has focused on symptoms such as 
sadness or lack of energy rather than a diagnosis of clinical depression and has therefore used 
screening instruments as assessment tools (Table 1-1and Table 1-2). Several studies have 
demonstrated that PD patient variables such as disease severity, health status and mood disorder are 
associated with caregiver depression (Caap-Ahlgren & Dehlin, 2002; Carter et al., 1998; Fernandez, 
Tabamo, David, & Friedman, 2001). Others have reported that patient depression itself is associated 
with caregiver depression (Aarsland, Larsen, Karlsen, Lim, & Tandberg, 1999; Meara, Mitchelmore, 
& Hobson, 1999). Meara and colleagues (1999) also reported that 64% of PD patients and 34% of 
caregivers scored within the depressed range on the Geriatric Depression Scale-15 (≥5; Weintraub, 
Oehlberg, Katz, & Stern, 2006). Other investigators have provided caregiver rates as high as 54% 
(Caap-Ahlgren & Dehlin, 2002) and as low as 9.1% (Martinez-Martin et al., 2008). The general 
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caregiving literature has provided caregiver depression rates of between 12.5% and 24% (Livingston, 
Manela, & Katona, 1996; Molyneux, McCarthy, McEniff, Cryan, & Conroy, 2008) and one 
Alzheimer’s disease study reported a 12.5% incidence of depression among mild cognitive impairment 
caregivers (Blieszner & Roberto, 2010). 
Anxiety is less frequently reported in the PD caregiving literature although it is often co-morbid 
with depression (Andreescu et al., 2007). One group found that anxiety was significantly associated 
with Zarit burden, although in multiple regression anxiety did not feature in the model (Martinez-
Martin et al., 2007) (Table 1-2). In a subsequent study Martinez-Martin and colleagues (2008) 
demonstrated that caregiver anxiety was related to disease severity, duration of care, costs and female 
gender, with 21.7% of caregivers and 25% of patients experiencing anxiety. Generally higher rates of 
anxiety (25%-57%) have been reported in the general caregiving literature (Cooper, Balamurali, & 
Livingston, 2007; Crespo, Lopez, & Zarit, 2005; Mahoney, Regan, Katona, & Livingston, 2005). 
1.3 Additional Factors Influencing PD Caregivers. 
Coping. 
While the main aim of the current study was to examine the influence of PD patient cognitive status on 
caregiver outcome, a secondary aim was to investigate the possible mediating effect of other factors on 
this relationship. The value of this addition is that the construct of coping has been used in related 
research such as Alzheimer’s disease, to explain variability in caregiver outcomes (Cooper, Katona, 
Orrell, & Livingston, 2008; Fillion, Kovacs, Gagnon, & Endler, 2003; Snell, Siegert, Hay-Smith, & 
Surgenor, 2011) and offers a focus for interventions (Pinquart & Sorensen, 2003; Sanders-Dewey, 
Mullins, & Chaney, 2001). Several theories of coping exist based on the early work of Lazarus and 
Folkman (1985) who conceptualized coping as an evaluation of a stressor, that shapes an individual’s 
emotional and behavioural reactions (Maes, Leventhal, &De Ridder, 1996). According to Lazarus 
(1993) coping is a process that changes over time and situation rather than a trait. This approach is 
appropriate in a study of PD caregivers in which the variables of interest relate to how caregivers cope 
with different levels of patient cognitive impairment.  
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Folkman and Lazarus (1986) derived two theory-based dimensions of coping, problem-focused 
and emotional-focused coping. A third dimension, dysfunctional coping, was added by Carver, Scheier 
and Weintraub (1989). Problem-focused coping relates to trying to manage distress through 
confronting and altering the situation and includes strategies such taking action to improve the 
situation, seeking social support and planning. Use of this strategy may however be maladaptive for 
caregivers dealing with a progressive neurological disease such as PD. When a threat is appraised as 
uncontrollable, emotional-focused coping strategies are elicited. Emotional –focused coping concerns 
attempts to reduce distress by regulating emotions and includes strategies such as using humour, 
finding support through religion, positive reframing and acceptance. Thus emotion-focused coping 
may prove more adaptive than problem-focused coping strategies in the context of PD in which 
attempts to change the situation could create frustration and disappointment. While debate remains 
over the merits and disadvantages of problem-focused and emotion-focused strategies, theorists agree 
that dysfunctional strategies are invariably associated with more negative outcomes; they include 
substance use, behavioural disengagement and self-distraction (Austenfeld & Stanton, 2004). 
One of 2 studies to examine coping in PD caregivers used the Revised Ways of Coping 
Checklist (WOCL), which includes only the problem-focused and emotion-focused dimensions of 
coping (Sanders-Dewey, Mullins, & Chaney, 2001). The authors reported that emotion-focused coping 
was found to be a significant predictor of caregiver distress in that more emotion-focused coping was 
associated with more distress. However in the WOCL instrument the emotion-focused dimension 
contains items of escape avoidance and distancing that are more similar to strategies described in other 
instruments as dysfunctional (Del-Pino-Casado, Frias-Osuna, Palomino-Moral, & Pancorbo-Hidalgo, 
2011). The second study that explored coping in PD caregiving used the Sense of Coherence Scale 
(SOC), which captures global states of coping rather than strategies (Caap-Ahlgren & Dehlin, 2002). 
The authors reported that low sense of coherence (coping) was a significant predictor of caregiver 
burden in that when caregivers felt they were not coping they experienced more burden.  
One longitudinal Alzheimer’s study found that emotion-focused coping protected caregivers 
from developing anxiety a year later (Cooper, Katona, Orrell, & Livingston, 2008) whereas 2 other 
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dementia caregiving studies provided evidence of increased caregiver burden with the use of emotion-
focused coping (Chou, LaMontagne, & Hepworth, 1999; Kramer, 1997). The evidence surrounding 
the adaptive or maladaptive potential of problem-focused coping in the general caregiving literature is 
also inconclusive (Chou, LaMontagne, & Hepworth, 1999; Montoro-Rodriguez & Gallagher-
Thompson, 2009). In an effort to look beyond the associations between variables, Cooper and 
colleagues (2008) also examined coping using mediation analyses. Those authors reported that coping 
itself mediated the consequences of burden while others have found that coping strategies mediate the 
relationship between patient characteristics and caregiver outcomes (Cooper, Katona, Orrell, & 
Livingston, 2008; Kim, Knight, & Longmire, 2007; Tuokko, Kristjansson, & Miller, 1995). Further 
investigation into the direction of these relationships is required (de Pal Casado).  
Positive Attributions of Caregiving. 
Caregiving can be difficult and is associated with many negative outcomes, but some Alzheimer’s 
caregivers report positivity towards their role (Tarlow et al., 2004). This perspective has not been 
applied in the PD context previously but offers an opportunity to expand current knowledge of the 
mechanisms determining outcomes (Pinquart & Sorensen, 2003). Tarlow and colleagues (2004) 
developed the Positive Attributions of Caregiving (PAC) to identify the positive aspects of caregiving 
in the dementia context although the instrument has yet to gain popularity. The instrument has been 
derived from the stress process model by Folkman (1986) where positive emotional outcomes 
facilitate continued coping which in turn reduces negative outcomes. This construct may have 
application in PD and act as a mediator between patient cognitive status and caregiver burden or as a 
factor related to coping. One large longitudinal study (n=243) found that low scores on PAC predicted 
AD caregiver burden and that PAC was negatively associated with caregiver depression (Hilgeman, 
Allen, DeCoster, & Burgio, 2007). In addition, AD caregivers who endorsed less PAC benefitted most 
from an intervention, consisting of a caregiver skill building programme, included in the study as an 
outcome variable.  
 
15 
 
Time Spent Caregiving. 
In addition to the caregiver and patient variables described above, time devoted to PD caregiving has 
also been linked to negative caregiver outcomes. Several studies have found higher distress among 
caregivers who spend more time per week providing assistance in everyday tasks (Happe & Berger, 
2002; Martinez-Martin et al., 2007; Schrag, Hovris, Morley, Quinn, & Jahanshahi, 2006). In another 
example of some of the inconsistences in the PD caregiving literature, a second study found there was 
no link between length of caregiving, when measured in years, and caregiver stress (McRae, Sherry, & 
Roper, 1999).  
1.4 Rationale for the Current Study 
The impact of cognition in PD on caregiver well-being is poorly documented. There are some reports 
of negative caregiver outcome in PD-D but none in PD-MCI. In the main the results of studies 
examining PD cognition in caregiving are conflicting. Recently published criteria characterise PD 
cognition into 3 levels of cognitive status, those patients with relatively normal cognition (PD-N), with 
mild cognitive impairment (PD-MCI) and with dementia (PD-D) (Litvan et al., 2012). While dementia 
can be expected to be associated with increased caregiver burden (Leroi, McDonald, Pantula, & 
Harbishettar, 2012; Thommessen et al., 2002), mild cognitive impairment and neurobehavioural 
symptoms may also generate increased risk of negative caregiver outcomes beyond that associated 
with the motor disorder that characterises PD. Hence this new perspective on PD patient cognitive 
status provides an opportunity to help clarify the influence of patient cognition on caregiver outcome. 
After the current study commenced, one study published evidence on the impact of PD-N, PD-
MCI and PD-D on caregivers (Leroi, McDonald, Pantula, & Harbishettar, 2012). The authors used a 
brief assessment battery of eight neuropsychological tests plus the Mini-Mental State Exam to classify 
PD patients according to level I Movement Disorders Society criteria (Litvan et al., 2012). As stated 
earlier, these authors reported significant Zarit burden differences between PD-N versus PD-D and 
PD-MCI versus PD-D, but not between PD-N versus PD-MCI. It was suggested that PD-MCI by 
definition would not include patients with functional impairment and therefore Zarit burden in this 
group would not be expected to differ significantly from those without any identified cognitive 
16 
 
impairment. However this premise requires further elucidation as it conflicts with the findings from 
Alzheimer’s caregiving studies (Bruce, McQuiggan, Williams, Westervelt, & Tremont, 2008; Garand, 
Dew, Eazor, DeKosky, & Reynolds, 2005) and also suggests that caregiver burden is independent of 
patient cognition and more related to patient functional impairment. A more comprehensive 
neuropsychological assessment may provide improved diagnostic certainty regarding cognitive 
classification and generate increased confidence in any associations between patient cognitive status 
and caregiver burden. 
The current study also further extended the work of Leroi and colleagues (2012) by 
investigating the possible mediating effects of caregivers coping strategies, positive attributions of 
caregiving and PD patients’ neuropsychiatric symptoms between patient cognitive status and caregiver 
Zarit burden. Mediating variables provide an opportunity to look beyond observed associations and 
may suggest pointers for intervention. The construct of coping has not been well investigated in PD 
caregiving (Caap-Ahlgren & Dehlin, 2002; Sanders-Dewey, Mullins, & Chaney, 2001) and no studies 
have investigated the positive aspects of PD caregiving. Several previous PD caregiving studies have 
found that patient neuropsychiatric symptoms are associated with caregiver burden (Aarsland et al., 
2007; Aarsland, Larsen, Karlsen, Lim, & Tandberg, 1999; Leiknes, Tysnes, Aarsland, & Larsen, 2010) 
and in at least one of these studies, cognitive status was also implicated (Aarsland et al., 2007).  
In the current study, caregivers were also asked an open-ended question: “What is the hardest 
thing about providing care/support to someone with Parkinson’s disease?” This additional qualitative 
question was added to complement the quantitative data obtained from the standardized questionnaires 
to allow potentially unasked issues to be raised.  
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2 METHOD 
2.1 Overview 
The current study employed a cross-sectional design to examine the influence of three levels of 
cognitive status in Parkinson’s disease on their caregivers. Ethical approval for this investigation was 
given by the New Zealand Ministry of Health Upper South Island A Regional Ethics Committee 
(Reference URA/11/11/067) and all participants gave informed consent. Copies of the information 
sheets and consent forms given to Parkinson’s disease patients and their significant others/caregivers 
are included in Appendix A. 
2.2 Participants 
One hundred and fifty five people who met the UK Parkinson’s Disease Society’s criteria for 
idiopathic Parkinson’s disease (Hughes, Daniel, Kilford, & Lees, 1992) were identified through the 
database at the New Zealand Brain Research Institute (NZBRI) in Christchurch. Caregivers were 
identified as any person who was directly involved in the patient’s care and provided some form of 
support with respect to everyday activities. In the caregiving literature terms such as caregiver, 
significant other and support person are used interchangeably. The caregiver did not need to be living 
with the PD patient and needed to complete self-assessment questionnaires. Only PD patients who had 
undertaken either detailed or brief cognitive assessment within 4 months of the caregiver interview 
were included. Of the 155 potential PD patients, 7 were unable to be contacted, 4 had died and 7 had 
no caregiver currently supporting them. A further 11 patients were about to undergo comprehensive 
neuropsychological assessment at the NZBRI for a separate study and were unable to undertake an 
additional study. Twenty two caregivers declined participating. A final sample of 104 patient-
caregivers provided data for the current study: 74 women and 30 men. Sixty-five caregivers came to 
the NZBRI for interview and 39 caregivers were interviewed in their own homes. There were 91 
spouses, 4 daughters, 4 sons, 1 brother, 1 daughter-in-law and 3 friend caregivers. Eighty nine 
caregivers lived with the person with PD; 15 caregivers lived at a separate address but spent a 
minimum of 4 hours a week caring for the PD patient.  
18 
 
Ninety eight percent of the PD patients identified themselves as being NZ European, 2% as 
Asian, none as Māori and none as Pacific Islanders, compared with Canterbury’s 77% NZ European, 
6% Asian and, 7% Māori and 2% Pacific Islander as provided by NZ’s 2006 Census statistics 
information (Statistics New Zealand, Census 2006). 
Classification of PD Patient Cognitive Status.  
The patients were classified as showing normal cognition (PD-N), mild cognitive impairment (PD-
MCI) or dementia (PD-D) (see Table 2-1 and Table 2-2 for assessments and Appendix B for further 
details). Sixty-seven PD patients had attended the NZBRI for detailed cognitive assessment relating to 
other studies within 4 months of the caregiver interview and these patients were classified by the 
assistant research fellow at the NZBRI (Lesley Livingston). Briefly, PD-D patients fulfilled the new 
diagnostic criteria of the Movement Disorders Society (Emre et al., 2007) as described in (Dalrymple-
Alford et al., 2011; 2010). PD-MCI patients did not show significant impairment in everyday function 
and were required to show two deficits at 1.5SD below normative data within at least one cognitive 
domain. The remaining patients were classified as showing normal cognition (PD-N). The 
classification of these three distinct groups of patients has been further confirmed with neuroimaging  
(Dalrymple-Alford et al., 2011; Melzer et al., 2013) and while basic language measures did not form 
part of their evaluation, this cognitive domain does not generally distinguish these groups (Emre, 2007 
and (Dalrymple-Alford et al., 2013). 
A further 28 patients undertook an abbreviated neuropsychological assessment by the author 
(AJ) and were classified using 3 measures across 2 domains: Letter fluency, action fluency (executive 
function) and months reversed (working memory), as well as the Montreal Cognitive Assessment and 
the Mini-Mental State Exam. Cognitive status for these patients was also established by caregiver 
reports of patient abilities daily living tasks and neuropsychiatric symptoms. Receiver operating 
characteristic (ROC) curve analyses were used to evaluate cognition across the 5 “domains” within the 
Montreal Cognitive Assessment. For the brief assessment, PD patients were classified as PD-MCI if 
they demonstrated impairment on at least 2 tests in one or more domains but with no significant 
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impairments in activities of daily living (Litvan et al., 2012). ROC curve analyses, comparing the 
MoCA subtest scores between PD-N (n=38) and PD-MCI (n=24) in patients with full cognitive 
assessment were used to identify suitable cutoff criteria. Diagnostic values were determined with > 
80% specificity [avoidance of true negatives] and 70-80% positive predictive values (PPV) [detection 
of an accurate positive test]. The optimal cutoff in MoCA items for visuospatial function was <4 (92% 
specificity, 77% PPV); for working memory < 2 (94% specificity, 78% PPV); for attention <5 (94% 
specificity, 78% PPV); for language <2 (specificity 97%, 67% PPV). The ROC curve comparisons of 
semantic memory and orientation were non-significant and were therefore excluded. A PD-D 
classification required a decline in everyday functional activities not attributed to motor impairment 
(ADL-IS; Reisberg, 2001), as demonstrated by scores on the mental status tests (<21 MoCA 
(Dalrymple-Alford et al., 2010) and a deficit in at least 2 cognitive domains (Emre, 2007). 
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Table 2-1 Individual PD patient neuropsychological test scores and domains (mean ± SD) n=67 
 PD-N(n=38-57) PD-MCI(n=24-31) PD-D(n=5-16) Analysis 
Attention, Working memory and 
Processing Speed 
    
   DigitsF/B 0.76 ± 0.9 0.12 ± 0.7 -0.14 ± 0.6 F2,73=8.67, p<.001 
   Digit Ordering -0.93 ± 0.9 -1.94 ± 0.5 -2.07 ± 0.8 F2,73=15.74, p<.001 
   TEA (Map Search) -0.41 ± 0.9 -1.43 ± 0.8 -1.69 ± 0.9 F2,72=16.29, p<.001 
   Stroop colour 0.10 ± 0.8 -0.43 ± 1.1 -1.14 ± 1.2 F2,73=8.82, p<.001 
   Stroop word 0.10 ± 0.9 -0.25 ± 0.9 -0.60 ± 1.1 F2,73=22.94, p<.001 
   Trails A 0.32 ± 0.7 -0.20 ± 0.8 -1.52 ± 1.3 F2,73=22.94, p<.001 
   Domain Score 0.01 ± 0.5 -0.69 ± 0.4 -1.18 ± 0.7 F2,72=29.90, p<.001 
Executive Function       
   Letter Fluencya 0.54 ± 1.3 0.16 ± 1.4 -0.97 ± 0.8 F2,73=3.55, p<.05 
   Action Fluencya 0.03 ± 1.0 -0.64 ± 1.0 -1.36 ± 0.9 F2,73=9.76, p<.001 
   Category Fluency  0.75 ± 1.1 0.24 ± 0.9 -0.76 ± 1.2 F2,73=9.87, p<.001 
   Category Switching 0.28 ± 1.3 -0.32 ± 1.1 -1.67 ± 1.2 F2,73=13.45, p<.001 
   Trails B 0.26 ± 1.0 -0.25 ± 0.9 -1.96 ± 1.3 F2,73=23.24, p<.001 
   Stroop 0.40 ± 0.9 -0.50 ± 1.2 -1.67 ± 1.2 F2,73=18.94, p<.001 
   Domain Score 0.42 ± 0.8 -0.15 ± 0.7 -1.31 ± 0.9 F2,72=29.90, p<.001 
2.2.1.1 Visuoperceptual 
Visuospatial 
     
   JOL 0.55 ± 0.6 -0.09 ± 0.9 0.02 ± 0.6 F2,73=5.90, p<.01 
   Fragmented letters 0.82 ± 0.5 0.42 ± 0.8 0.27 ± 1.0 F2,73=3.75, p<.05 
   Rey Copy 0.09 ± 1.0 -0.77 ± 1.3 -1.23 ± 1.4 F2,73=7.92, p<.001 
   Domain Score 0.50 ± 0.4 -0.10 ± 0.6 -0.31 ± 0.7 F2,72=29.90, p=.001 
Learning & Memory      
   CVLT Free recall 0.75 ± 1.1 -0.25 ± 0.9 -1.11 ± 1.2 F2,73=17.10, p<.001 
   CVLT Short delay 0.57 ± 1.3 -0.27 ± 1.2 -1.29 ± 0.7 F2,73=12.73, p<.001 
   CVLT Long delay 0.54 ± 0.9 -0.38 ± 1.0 -0.64 ± 0.5 F2,73=11.57, p<.001 
   Rey Immediate 0.75 ± 1.5 -0.51 ± 1.3 -1.09 ± 1.0 F2,72=11.61, p<.001 
   Rey Delayed 0.71 ± 1.7 -0.77 ± 1.3 -1.41 ± 1.3 F2,70=11.63, p<.001 
   Domain Score 0.66 ± 1.2 -0.43 ± 0.8 -1.12 ± 0.7 F2,72=29.90, p<.001 
Global neuropsychological Z 
score 
-0.91 ± 0.3 -0.39 ± 0.4 -0.91 ± 0.3 F2,73=3.87, p<.05 
PD-N, n=38; PD-MCI, n=24; PD-D, n=5, except a:  PD-N, n= 57; PD-MCI, n= 31; PD-D, n=16 - these additions had abbreviated 
testing only whereas other non-dementia patients had detailed testing. PD-D patients received detailed testing and a confirmed 
diagnosis between 2 weeks and 4 years previously. 
For details of tests see Appendix B 
 
Table 2-2. Individual PD patient global cognitive assessment scores (mean ± SD) (n=104). 
 PD-N(n=19-57) PD-MCI(n=7-31) PD-D(n=2-16) Analysis 
MoCA  26.59 ± 2.28 24.47± 2.49 20.65± 3.36 F2,101 = 27.67, p<.001 
MMSE  28.78 ± 1.41 27.37 ± 1.97 24.21 ± 3.11 F2,101 = 32.869, p<.001 
ADL-IS  0.58±0.59 0.63 ± 0.53 1.69 ±0.690 F2,99 =23.073, p<.001 
Months 
reverseda 
18 P, 0 F 6 P, 2 F 1 P, 1 F  
PD-N, n=57; PD-MCI, n=31; PD-D, n=16, except a:  PD-N, n= 19; PD-MCI, n= 7; PD-D, n=2 - only these patients did months 
reversed. PD-D patients received detailed testing and a confirmed diagnosis between 2 weeks and 4 years previously. 
For details of tests see Appendix B 
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2.3 Caregiver Measures.  
Caregivers were given 5 questionnaires concerning burden, coping strategies, positive attributions 
towards caregiving and personal depression and anxiety symptoms. Demographic information 
included the number of hours spent caregiving per week. In addition to the 5 questionnaires, 
caregivers who provided care for those PD patients who had not had detailed neuropsychological 
assessment within 4 months of the caregiver interview also completed instruments to assess the PD 
patient’s everyday functional activities (Reisburg et al., 2001) and neuropsychiatric symptoms 
(Cummings et al., 1994).  
Caregiver Measures: For PD Patients with Full and Brief Cognitive Assessment. 
Burden.  
The Zarit Burden Interview (Zarit, Reever, & Bach-Peterson, 1980) is the most widely used measure 
of caregiver burden (Ankri, Andrieu, Beaufils, Grand, & Henrard, 2005). Originally designed for use 
in the impaired elderly, the self-report measure has shown applicability in a variety of populations. 
Scores are unrelated to age, gender, living situation, locale, language, marital status or employment 
status. In dementia caregivers, the measure has good internal consistency reliability with a Cronbach’s 
alpha of .92 (Hebert, Bravo, & Preville, 2000). 
The ZBI (Appendix C-1) identifies the impact of the patient’s disability on the caregiver/support 
person in terms of health, finances, social life and interpersonal relations. There are 22 items in the 
scale and participants were asked to choose the response that “best describes how they feel”: never, 
rarely, sometimes, quite frequently or nearly always. The scores were summed with higher scores 
indicating greater caregiver/support person distress. Scores between 0 - 21 suggests no to mild burden; 
21 - 40 = mild – moderate burden; 41 - 60 = moderate to severe burden; 61-88 = severe burden (Zarit, 
Reever, & Bach-Peterson, 1980). 
Coping.  
The brief Coping Orientations for Problems Experienced (COPE) assesses different coping strategies 
and is a shortened version of the 60 item COPE Inventory (Carver, 1997). The brief COPE (Appendix 
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C-2) omits 2 scales from the full COPE, adds one new scale and reduces the instrument from 4 to 2 
items per scale. This self-report instrument has been used in health-related research including 
dementia caregivers (Cooper, Katona, Orrell, & Livingston, 2008; Crespo, Lopez, & Zarit, 2005). 
Carver (1997) suggests that the questionnaire can be modified to suit the research design and the 
wording adjusted depending on whether dispositional or situational coping is the construct of interest. 
The current study aimed to capture the caregiving experience at one point in time, therefore caregivers 
were asked to consider their current PD caregiving situation.  
Responses were scored on a 4 point Likert scale ranging from 1 (“I haven’t been doing this at 
all”) to 4 (“I have been doing this a lot”). The brief COPE contains 28 items measuring 14 distinct 
coping reactions to stressful life events. Previously published literature has used 9, 3 and 2 factor 
solutions for the brief COPE (Carver, Scheier, & Weintraub, 1989; Cooper, Katona, Orrell, & 
Livingston, 2008; Snell, Siegert, Hay-Smith, & Surgenor). Principal components factor analysis on the 
current caregiver responses found a 3 factor solution, similar to that described by Cooper and 
colleagues (2008) in which items on the brief COPE formed clusters called problem-focused, emotion-
focused and dysfunctional coping. The principal components factor analysis methodology used to 
derive the 3 factor solution is described in Appendix D. In brief, problem-focused coping included the 
subscale items: Active coping, seeking instrumental support, seeking emotional-support and planning; 
emotion-focused coping included: Religion, acceptance, humour and one item from the positive 
reframing subscale; dysfunctional coping included: Self-distraction, substance use, behavioural 
disengagement and venting.  
Positive Attributions.  
The Positive Aspects of Caregiving scale (PAC) is a 9-item measure designed for use in a range of 
caregiving environments to evaluate the positive dimensions of the caregiving experience (Tarlow et 
al., 2004). Each of the items begins with “Providing help to (name) has....” followed with specific 
items such as “Made me feel more useful” and “Enabled me to appreciate life more.” Each item was 
rated on an ordinal scale ranging from 1 (disagree a lot) through to 5 (agree a lot). The items are 
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summed to give a total score for each participant. The reliability of the nine items was reported as 
high: Cronbach’s alpha = 0.89 (Tarlow et al., 2004). 
The PAC (Appendix C-3) was developed from previous work of Lawton and colleagues (1989, 
1991). However the current PAC differed from this original measure in that: (1) items were changed 
from a yes/no format to increase variability of responses and improve reliability; (2) questions were 
rephrased as statements to allow response options; and (3) the instructions were simplified to aid 
administration.  
Depression.  
The 15-item Geriatric Depression Scale (GDS-15; Weintraub, Oehlberg, Katz, & Stern, 2006) is a 
screening instrument for depression in elderly populations (Appendix C-4). Participants were first 
presented with 4 questions relating to feelings of depression: eg. “Are you basically satisfied with your 
life?” If the caregiver agreed with any of these 4 statements another 11 statements were presented. For 
the GDS-15, 0-4=depression unlikely; 5-10= mild depression; > 10 are almost always depressed. The 
GDS has shown good internal consistency and validity in both elderly and younger populations (Rule, 
Harvery, & Dobbs, 2008). 
Anxiety.  
The geriatric anxiety inventory (GAI) is a 20-item self-report scale of agree/disagree statements which 
is able to discriminate between those with or without anxiety symptoms and those with and without 
DSMIV Generalized Anxiety Disorder (GAD). Participants were initially presented with 5 statements 
relating to feelings of anxiousness: eg. “I often feel nervous”. If the caregiver agreed with 3 or more 
statements the further 15 statements were presented and a total score given: 0-1= anxiety unlikely; 2-
8= mild anxiety; ≥9= possible anxiety disorder (Pachana et al., 2007). The instrument is provided in 
Appendix C-5. 
 
“The Hardest Thing” 
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At the end of the interview caregivers were asked the single question, “What is the hardest thing about 
providing care/support to someone with PD?” When several difficult aspects of the role were provided 
the caregivers were encouraged to choose the most difficult of those options. These responses were 
recorded as falling into one of 8 categories: difficulties relating to personal or social interactions; 
nothing specifically relating to PD eg. “nothing in particular” or “I just don’t love him any more”; 
physical symptomology of PD; worrying about the future; patient dependency; lack of time for 
oneself; whether to help the patient while they struggled to complete tasks; specific aspects of PD 
relating to individual caregivers eg. “The time taken to diagnose PD”. 
Premorbid IQ 
Premorbid IQ of the caregivers was calculated based on occupation, years of education and age using 
the equation: 87.14 - (5.21 x occupation) + (1.78 x education) + (. 18 x age) to derive a full scale IQ 
(FSIQ) according to Crawford and colleagues (2001). Each participant’s occupation was coded using 
the Office of Population Censuses and Surveys (1980). The Classification of Occupations consisted of 
five categories broadly defined as follows; 1 = professional, 2 = intermediate, 3 = skilled, 4 = semi-
skilled, 5 = unskilled. Retired participants, and those describing themselves as 
househusbands/housewives, were coded by their previous occupations as were those currently 
unemployed. Those who had never worked were coded as 5 (i.e., unskilled).  
Statistical analysis 
One hundred four caregivers provided 95% power for a large effect size (f = 0.4). Analysis of 
variance, Chi square and t-tests were used to assess the relationships between demographic and 
clinical measures with caregiver outcome; multivariate analyses (linear, multiple regressions and path 
analyses) were employed to determine mediators of caregiver burden.  
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3 RESULTS 
The demographic and clinical details for the PD patients and caregivers are shown in Table 3-1 and 
Table 3-2 respectively. The PD patients were aged between 48 to 82 years with 72% male and a mean 
educational level of 12.5 years; 98% identified themselves as New Zealand European (Table 3-1). 
Disease duration ranged from 1.5 to 31 years. Patients in the 3 cognitive status groups did not differ 
significantly in age, years of education, depression, anxiety or movement difficulties (UPDRS) (Table 
3-1). Caregivers were aged between 23 and 83 years old, were predominantly a spouse (88%) and 
female (71%); their mean education duration was 12 years; 96% identified themselves as New Zealand 
European and 86% lived with the person with PD (Table 3-2). Caregivers of PD patients in the 3 
cognitive status groups did not differ in age or years of education.  
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Table 3-1. Parkinson’s disease patient demographic and clinical characteristics. 
 PD-N PD-MCI PD-D Analysis Post Hoc 
n 57 31 16   
Age 68.15 ± 8.1 70.23 ± 6.7 73.06 ± 4.8 F2,101 =3.03, ns  
Female:Male 1:2.2 1:2.8 1:3   
Years Education 12.72 ± 2.6 12.37 ± 2.4 12.41 ± 2.7 F2,101 <1.0  
Eth:NZer/Other* 56/1 30/1 16/0   
NPIa  3.43 ± 0.8 5.79 ± 0.9  9.85 ± 1.5 F2, 91 = 10.12, p < 0.001 PD-N v PD-D p < .001;  
     PD-MCI v PD-D p < .001 
UPDRSb  23.89 ± 1.8 30.17 ± 2.9 36.20 ± 5.7 F2,64 = 3.32, p<.05 Nil 
Disease duration 6.41 ± 3.7 8.05 ± 4.5 12.94 ± 7.5 F2, 101 = 12.02, p<.0001 PD-N v PD-D p < .001 
     PD-MCI v PD-D p < .001 
GDSc  1.13 ± 2.3 1.33 ± 2.5 1.5 ± 2.4 F2,92  < 1.0  
HADSd  4.7 ± 2.7 7.35 ± 3.1 7.5 ± .7 F2,41 < 1.0  
ADL-ISe  .54 ± .5 .68 ± .4 2.04 ± .6 F2,91 = 34.63, p <.0001 PD-N v PD-D, p < .001 
     PD-MCI v PD-D p < .001 
Values reported as mean ± standard deviation; Eth:NZer = Ethnicity New Zealander/*Other = Chinese, Vietnamese and 
Mixed; NPI (n=94) Neuropsychiatric Inventory; UPDRS Unified Parkinson’s Disease Rating Scale; GDS Geriatric 
Depression Inventory; HADS Hospital Anxiety and Depression Scale; ADL-IS Activities of Daily Living – International 
Scale (max=4.0); a n=56 PD-N, 31 PD-MCI, 7 PD-D; b n= 38 PD-N, 24 PD-MCI 5 PD-D; c n= 56 PD-N, 31 PD-MCI, 7 PD-
D; d n= 22 PD-N, 20 PD-MCI, 2 PD-D; e n=56 PD-N, 31 PD-MCI, 7 PD-D.  
 
 
Table 3-2. Caregiver demographic variables. 
 PD-N PD-MCI PD-D Analysis 
n 57 31 16  
Age 65.2 ± 9.6 62.2 ± 13.3 67.9 ± 11.7 F2,101 <1.0 
Female/Male 2.4:1 2.4:1 3:1  
Years Education 12.3±2.1 12.3±2.7 11.5±1.8 F2,101 <1.0 
Eth:NZer/Other* 54/3 30/1 16/0  
Spouse/Otherb 53/4 25/6 13/3  
Lives separately 3 7 5  
PACc 26.9±8.9 25.48±9.8 24.3±9.3 F2,101<1.0 
Scores reported as mean ± standard deviation; Eth:NZer = Ethnicity New Zealander/*Other = Chinese, Vietnamese and 
Mixed; bDaughter, son, daughter-in-law, brother or friend; cPAC Positive Attributions of Caregiving 
 
3.1 The Influence of Cognitive Status on Caregiver Outcome 
Mean Zarit Burden scores differed significantly between caregivers for patients across the 3 cognitive 
status groups (F (2,101) = 9.96, p < .001) (Figure 3-1a). Caregivers for PD-MCI patients had Zarit 
Burden ratings that were intermediate to those caregivers for PD-N and PD-D patients. Post hoc tests 
(Newman-Keuls) confirmed significant differences between all 3 groups: PD-N versus PD-MCI,         
p < .05; PD-N versus PD-D, p < .001; and PD-MCI versus PD-D, p < .05. Analyses of effect sizes for 
the differences between groups identified large effect sizes between PD-N versus PD-D (Cohen’s d = 
1.2) and PD-MCI versus PD-D (Cohen’s d = .62) and a medium effect size between PD-N versus PD-
MCI (Cohen’s d = .59). The proportion of carers showing significant burden scores (Zarit burden 
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score ≥ 21; Zarit, Reever, & Bach-Peterson, 1980) was 21% for PD-N, but rose to 58% for PD-MCI 
and 81% for PD-D (χ2 = 23.73, p < .001). All PD-D patients had received full assessment that 
confirmed their diagnostic status. Most other PD patients received full assessment (n = 62) to validate 
PD-N versus PD-MCI cognitive status but some patients (n = 28) had only brief assessments. The 
factor full versus brief assessment was therefore used in a supplementary analysis. There was no 
significant interaction between the effects of PD patient cognitive status and full versus brief cognitive 
assessment on mean Zarit burden scores (F(2, 84) < 1.0) and no overall differences in Zarit burden 
scores between carers of patients with full (mean=17.66, SE = 1.5) versus brief (mean = 17.51, SE = 
2.6) cognitive assessment (F(1, 84) < 1.0) . As expected, differences between PD-N (mean = 14.03, 
SE = 1.6) and PD-MCI (mean = 21.14, SE = 2.5) caregiver burden scores remained significant (F(1, 
84) = 5.47, p < .05). Hence the total sample of PD-N and PD-MCI patients was regarded as valid. 
Unified Parkinson’s Disease Rating Scale scores (n = 67) available from patients within 4 
months of caregiver interview did not correlate with caregiver burden (r(102) =.09). Moreover, the 
significant effect of patient cognitive status between PD-N and PD-MCI on caregiver burden remained 
after controlling for the effects of this PD motor rating (F(2,62)=8.96, p<.005). In a separate analysis         
(n = 94), neuropsychiatric scores were also included as a covariate to remove the possible confounding 
effects of PD patient neurobehavioural symptoms. The significant effect of patient cognitive status 
also remained when patient neuropsychiatric symptoms were added as a covariate F(2, 90) = 4.44, p < 
= .05. Additionally, in further analyses (n=104) caregiver depression and anxiety were also included as 
covariates, which if anything increased the Zarit burden differences between the three patient 
cognitive status groups (depression, F(2, 100) = 15.98, p = .0001; and anxiety, F(2, 100) = 12.71, p = 
.0001).  
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Figure 3-1 
a Burden experienced by caregivers as measured with the Zarit Burden Interview as a function of 
cognitive status of the caregiver; b Mean depression scores of caregivers as a function of cognitive status 
of the PD patients; c Mean anxiety scores of caregivers as a function of cognitive status of the PD patients; 
d Positive Attributions towards caregiving as expressed by caregivers as a function of the PD patients; e 
Mean number of hours spent caregiving as a function of cognitive status of the PD patients.  
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3.2 Anxiety, Depression and Positive Attributions in Caregivers as a Function of PD 
Patient Cognitive Status  
Seven per cent of caregivers and 10% of PD patients had symptoms of mild depression as measured 
with the Geriatric Depression Scale (GDS score > 5/15;Weintraub, Oehlberg, Katz, & Stern, 2006). 
Mean GDS scores did not differ significantly between caregivers for patients in the 3 cognitive status 
groups (F (2,101) = 2.09, p =.13) (Figure 3-1b). There was a significant but low correlation between 
the depression scores of the caregivers and those of the PD patients as measured with the GDS: 
r(93)=.22, p<.05.  
Thirty-six percent of all caregivers (n=104) scored in the mild anxiety range and 8% of these 
scored in the possible anxiety disorder range. Mean Geriatric Anxiety Inventory scores did not differ 
significantly between caregivers for patients in the 3 cognitive status groups (F (2,101) = 1.61, p = 
.20) (Figure 3-1c). Among PD-D caregivers 25% had mild anxiety (≤ 8 and ≥2; Pachana et al., 2007) 
but none had a possible anxiety disorder (GAI score ≥ 9;Pachana et al., 2007). 32% PD-MCI 
caregivers had mild anxiety and 7% presented with a possible anxiety disorder. 42% PD-N caregivers 
had mild anxiety and 9% had a possible anxiety disorder. Patient anxiety scores (HADS) did not 
correlate significantly with GAI caregiver scores r(43) = -.07, ns. 
Positive Attributions towards Caregiving scores did not differ between caregivers in the three 
cognitive status groups (Figure 3-1d). 
3.3 Time Spent Caregiving. 
The number of hours that caregivers spent per week caring for PD patients increased significantly 
between caregivers in the 3 cognitive status groups (F(2, 101) =7.04, p < .01) (Figure 3 1e). Post hoc 
tests showed a significant difference between PD-N versus PD-MCI p < .05, PD-N versus PD-D p < 
.01, but it was interesting that this was not the case not between PD-MCI versus PD-D p = .29. 
Analyses of effect sizes for the differences between groups identified medium to large effect sizes 
between PD-N versus PD-MCI (Cohen’s d = .60) and PD-N versus PD-D (Cohen’s d = .88) but only a 
small effect size between PD-MCI and PD-D (Cohen’s d = .22). 
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3.4 Gender differences  
There were no significant differences in Zarit burden scores between female and male caregivers in 
PD-N (t(55) = .91, p = .36); PD-MCI (t(29)=.44, p = .66) and PD-D (t=.58, p = .56) (Table 3-3). 
 
Table 3-3. Gender differences in mean Zarit burden scores. 
 
 
 
3.5 Caregiver Coping 
The total mean score of all 28 coping items also increased significantly as a function of the patients’ 
cognitive status (F(2, 101) = 3.09, p < .05) (Figure 3-2). Post hoc tests (Newman-Keuls) showed 
significantly lower total scores in PD-N versus PD-D caregivers (p<.05) but not between PD-N versus 
PD-MCI caregivers (p = .32) or PD-MCI versus PD-D caregivers (p = .13). Analyses of effect sizes 
for the differences between groups identified a small effect size between PD-N versus PD-MCI 
(Cohen’s d = .22), a medium effect size for PD-MCI versus PD-D (Cohen’s d = .55) and a large effect 
size between PD-N and PD-D (Cohen’s d = .84). Three dimensions of coping, problem-focused, 
emotion-focused and dysfunctional were identified from the 28 items of the Brief COPE with factor 
analysis, which is described in detail in Appendix D. Restricting total mean scores to the factor 
derived dimensions yielded similar results: Total mean factor derived scores increased significantly 
between caregivers of patients in the 3 cognitive status groups F(2,101) = 4.21, p < .05 and post hoc 
tests showed significantly lower total scores in PD-N versus PD-D patients (p < .05) but not between 
PD-N versus PD-MCI patients (p = .29) or PD-MCI versus PD-D patients (p = .06). Female caregivers 
employed more coping strategies in total than males (t(104)= 2.1, p < .05).  
 
 
 
 Zarit Burden Score 
 
   Female Male F/M 
PD-N 15.07(n=40) 11.88(n=17) 2.4:1 
  PD-MCI 21.64(n=22) 19.67(n=9) 2.4:1 
PD-D   28.67(n=12) 25(n=4) 3:1 
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COPE Coping Orientations for Problems Experienced 
Figure 3-2. Total mean scores for number of coping strategies used by caregivers as a function of cognitive 
status of the PD patients (n=104).  
 
The use of coping strategies by PD caregivers was examined for each of the 3 dimension scores 
derived from the factor analysis of the Brief COPE instrument (Figure 3-3). The factor derived 
dimensions, problem-focused coping, emotion-focused coping and dysfunctional, excluded the 2 self-
blame items, 2 denial items and 1 positive reframing item. As the emotion-focused dimension 
contained 7 items and the problem-focused and dysfunctional dimensions contained 8 items, scores 
were averaged and are provided in Table 3-4. There was no difference between the 3 cognitive status 
groups in the use of emotion-focused coping (F(2, 101) = 1.70, p = .19) or dysfunctional coping 
strategies (F(2, 101) = 1.95, p = .15). However there was a significant difference between the groups 
in the use of problem-focused coping strategies (F(2, 101) = 4.05, p < .05). Post hoc tests (Newman-
Keuls) revealed that PD-N caregivers used significantly less problem-focused coping strategies than 
PD–D (p < .05); PD-MCI caregivers used less than PD-D (p < .05); there was no difference between 
PD-N versus PD-MCI (p = .39) in problem-focused coping. Analyses of effect sizes for the differences 
between groups identified a small effect size between PD-N versus PD-MCI (Cohen’s d = .23), and 
medium to large effect sizes between PD-N versus PD-D (Cohen’s d = 94) and PD-MCI and PD-D 
(Cohen’s d = = .67). 
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P-F Coping   Problem-focused coping 
E-F Coping   Emotion-focused coping 
Dysf Coping Dysfunctional coping 
Table 3-4. Subscale scores on the Brief COPE  
 PD-N PD-MCI PD-D  
Brief COPEa     
Problem-focused Dimensionb 1.85± 2.01± 2.38±  
Active Copingc 1.89±0.79 2.06±0.91 2.44±0.91  
Emotional Supportc 1.82±0.90 1.81±0.74 2.22±0.77  
Instrumental Supportc 1.57±0.65 1.82±0.76 2.25±1.10  
Planningc 2.14±0.86 2.34±1.03 2.63±0.81  
Emotion-focused Dimensionb 1.95± 2.12± 2.21±  
Positive Reframing 2c 1.95±0.87 2.32±2.01 1.81±0.98  
Humourc 1.50±0.65 1.90±0.89 1.91±0.76  
Acceptancec 2.77±0.96 3.00±1.05 3.44±0.68  
Religionc 1.66±0.94 1.53±0.90 1.34±0.57  
Dysfunctional Dimensionb 1.31± 1.34± 1.51±  
Substance Usec 1.07±0.31 1.03±0.12 1.16±0.30  
Ventingc 1.48±0.60 1.61±0.75 1.56±0.44  
Self-Distractionc 1.52±0.80 1.52±0.74 2.28±1.08  
Behavioural Disengagementc 1.13±0.38 1.21±0.40 1.03±0.13  
a High scores on the Brief COPE subscales indicate higher use of the respective coping strategy 
b Dimension Scores derived from factor analysis of the Brief COPE described in Appendix D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-3. Total number of coping strategies used by caregivers as a function of cognitive status of the PD 
patients (n=104). 
 
3.1 Correlations between Caregiver and PD Patient Characteristics 
Four measures of PD patient cognition (z score, Montreal Cognitive Assessment, Mini-Mental State 
Exam and cognitive status), correlated inversely with Zarit burden, ie. more burden with lower 
cognitive ability (Table 3-5). All 3 types of coping strategy significantly correlated with Zarit burden 
but only problem-focused also correlated with PD patient cognitive status. Neuropsychiatric 
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symptoms, activities of daily living and disease duration also significantly correlated with both Zarit 
burden and cognitive status. Caregiver burden, anxiety and depression did not correlate with 
caregivers difficulties relating to the recent Christchurch earthquakes and aftershocks: r(104) = -.13, p 
= .15; r(104) = -.15, p = -.14; r(104) = -.05, p = .61 respectively.  
 
Table 3-5 Correlations between measures of caregiver distress and clinical characteristics of the PD 
patients (n=104 unless otherwise stated). 
 ZBI GAI GDS PAC CogStat 
Patient Variables      
z score  -.20*   .14  .11   .03   .20* 
MoCA score  -.21*
 
  .17   .20*   .22*  -.59* 
MMSE score -.24*   .10 .10   .17  -.58* 
Cognitive Status -.41*  -.17 -.19   .11 1.00 
Disease Duration  .47*
 
  .21*
 
  .27*
 
  .09   .22* 
NPI   .42*
 
  .14  .09   .03   .38* 
ADL-IS   .56*
 
  .01  .12  -.04   .46* 
PATGDS  .28*
 
  .28*
 
  .23*
 
  .01   .04 
UPDRS  .09   .14  .02   .13   .31* 
Caregiver Variables      
Age  .01  -.13 -.06  -.20*  -.10 
PMIQ  .09  -.01  .08  -.16  -.09 
Hours Caring  .36*
 
 -.03  .07   .01   .34* 
P-F Coping  .56*
 
  .09  .02   .10  -.26* 
E-F Coping  .38*
 
  .07 -.07   .25*  -.18 
Dysf Coping  .68*
 
  .30*
 
  .19*
 
 -.07  -.18 
GAI  .18 1.00  .56*   .19  -.08 
CGGDS  .29*   .56* 1.00   .01  -.17 
PAC -.01   .19 .01 1.00  -.13 
Spearman correlations. * <0.05. MoCA (n=94) Montreal Cognitive Assessment; NPI (n=94) Neuropsychiatric Inventory; 
ADL-IS (n=94) Activities of Daily Living-Instrumental Scale; CGGDS Caregiver Geriatric Depression Inventory; PatGDS 
Caregiver Geriatric Depression Inventory HrsCr Hours spent caring’ P-F Coping Problem-focused coping; EF Coping 
Emotion-focused coping; Dysf Coping Dysfunctional coping; PAC Positive Attributions towards caregiving; PMIQ 
Premorbid Intelligence Quotient. CogSt Cognitive Status; z score (n=67).  
 
3.2  Mediators of Caregiver Burden  
The associations between PD patient cognitive status, coping and caregiver Zarit burden were first 
examined to find support for the use of path analysis to examine the mediator effect of coping between 
PD patient cognitive status and caregiver burden (Table 3-5). Emotion focused and dysfunctional 
coping failed to meet criteria as there were no significant associations between cognitive status and 
either emotion-focused coping (r = .17) or dysfunctional coping (r = .18). However problem-focused 
coping was independently associated with caregiver burden and cognitive status and therefore met 
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criteria for path analysis (Figure 3-4). The standardized regression coefficient between cognitive status 
and caregiver burden (.41) decreased substantially (to .28) when controlling for problem-focused 
coping strategies. Both the Sobel test (www.quantpsy.org/sobel/sobel.htm) and the method suggested 
by Preacher and Hayes (2004) that incorporates bootstrapping to obtain a confidence interval (CI) for 
the mediated effect were used to assess the mediator model. A mediator is significant when the 95% 
CI does not include zero. The change in the model reflecting mediation was found to be significant 
according to both methods: Sobel test: z = 2.56, p < .05; unstandardized indirect effect from 
bootstrapping procedure: b = 2.48, SE = .99, CI = 0.49, 4.38. Unfortunately, we cannot rely on the 
directionality of this model because the inverse model with Zarit burden, instead, mediating a link 
between cognitive status and problem-focused coping was also significant: Sobel test: z = 3.76, p<.01; 
unstandardized indirect effect from bootstrapping procedure: b = 3.56, SE = .06, CI = 0.10, 0.34. 
 
 
 
 
 
Figure 3-4. Standardized regression coefficients for the relationship between PD patient cognitive status 
and caregiver burden as mediated by use of coping strategies (n=104). The standardized regression 
coefficient between cognitive status and burden controlling for coping strategies is in parentheses *p<.05. 
 
Patient neuropsychiatric symptoms, disease duration and activities of daily living also all met 
the criteria for mediation analysis: Each was independently associated with both cognitive status and 
caregiver burden. However by definition, activities of daily living are included in cognitive status 
classification and disease duration is suggestive of worsening cognition, therefore only 
neuropsychiatric symptoms were submitted to path analysis (Figure 3-5). The standardized regression 
coefficient between cognitive status (.39) and caregiver burden decreased (.26) when controlling for 
patient neuropsychiatric symptoms. The change in the model reflecting mediation was found to be 
significant: Sobel test: z = 2.96, p < .01; unstandardized indirect effect from bootstrapping procedure: 
Problem-Focused  
Coping 
Burden PD Patient 
Cognitive Status 
.58* (.48*) 
.41 * (.28*) 
.26* 
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b = 2.44, SE = .96, CI = 0.41, 5.38. The inverse model (Zarit burden mediating the association 
between cognitive status and NPI) was not examined as it is not theoretically possible.  
 
 
 
 
Figure 3-5. Standardized regression coefficients for the relationship between PD patient cognitive status 
and caregiver burden as mediated by PD patient neuropsychiatric symptoms (n=94). The standardized 
regression coefficient between cognitive status and burden controlling neuropsychiatric symptoms is in 
parentheses *p<.05. 
 
 
The “Hardest Thing” 
The caregiver responses to the open-ended question, “What is the hardest thing about providing 
support to someone with Parkinson’s disease?” is provided in Figure 3-6. The majority of caregivers 
reported that it was the impact/drawback of reduced personal or social communication that they found 
most challenging. eg. “I have lost my best friend.” Examples of ‘Non-specific’ responses included 
“Nothing in particular” and “He’s so grumpy and irritable now.” Example of ‘Other’ included “It took 
two years before doctors could provide a diagnosis”. Fifty six percent of PD-D caregivers felt that 
social communication was the “hardest thing” compared with 35% PD-MCI and 28% PD-N. 
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Soc/comm Personal and social communication; Non-spec Nothing or not specific to PD’ Phys Physical symptoms of PD; Pat 
dep Patient dependence on caregiver; Time-self Time for self; ? Assist Being unsure whether to help the PD patient or not; 
Other Specific individual concerns.  
Figure 3-6. The percentage of caregiver responses to the question “What is the hardest thing about 
providing support/care to someone with Parkinson’s disease?” as a function of cognitive status of the PD 
patients (n=104). 
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4 DISCUSSION  
The current study sought to investigate the impact of PD patient cognition on caregiver outcome 
including caregiver burden, depression and anxiety. Additionally, the potential mediating effects of 
caregiver coping strategies and positive attributions towards caregiving between PD patient cognitive 
status and caregiver burden were examined. A qualitative question “What is the hardest thing about 
providing support/care for someone with Parkinson’s disease” was added to provide an insight to the 
carer’s global perspective.  
4.1 Summary of Findings 
Patients in the current study were classified as showing PD-N, PD-MCI or PD-D. The caregiver mean 
Zarit burden scores increased significantly between caregivers for patients between each of these three 
cognitive status groups. This investigation reports for the first time increased burden among carers of 
PD-MCI patients compared with those of PD-N. The findings were in contrast to the only other study 
to investigate caregiver burden for patients classified as PD-MCI (Leroi, McDonald, Pantula, & 
Harbishettar, 2012). Leroi and colleagues (2012) reported that although the mean burden score for PD-
MCI caregivers (23.61) was above the ≥ 21 threshold set by Zarit (Zarit, Reever, & Bach-Peterson, 
1980) this was similar to the mean burden score for PD-N caregivers (20.41). Only caregivers of PD-D 
patients showed relatively increased burden (35.48).  
The total mean coping scores also increased with worsening cognition. PD-MCI caregivers’ 
total scores were intermediate to PD-N and PD-D caregivers with a large difference in values between 
PD-N versus PD-D caregivers. Problem-focused coping, however, was the only strategy to differ 
between caregivers for patients in the three cognitive status groups with a similar pattern to that 
evident for total coping strategies. All three coping strategies were associated with caregiver Zarit 
burden, but only problem-focused coping strategies were associated with cognitive status. The 
relationship between PD patient cognitive status and caregiver burden may in part be mediated by 
caregiver problem-focused coping, as well as patient neuropsychiatric symptoms. 
Caregiver symptoms of depression and anxiety were not associated with cognitive status. The 
rates of depression symptoms among the caregivers were less than those reported in other PD 
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caregiving studies (Caap-Ahlgren & Dehlin, 2002; Martinez-Martin et al., 2008; Meara, Mitchelmore, 
& Hobson, 1999), while rates of anxiety symptoms were greater in comparison with other similar 
investigations (Martinez-Martin et al., 2008). 
Caregivers spent more time caring with worsening cognition and PD-MCI caregivers spent time 
that was close to PD-D caregivers. These between group differences were large between PD-N versus 
PD-MCI and between PD-N and PD-D. The additional qualitative question: “What is the hardest thing 
about providing support for someone with Parkinson’s disease?” showed that social communication 
was the most common concern among carers, which was more frequent in the PD-D carers. 
Sample Characteristics Compared with Other PD Caregiving Studies 
The composition of the PD Patients and caregivers was comparable to recently published PD 
caregiving patient samples in terms of PD diagnostic methods, range of cognitive impairment, gender, 
age and education (Table 1-1 and Table 1-2). Among previously published PD caregiving studies there 
was some heterogeneity in use of the term ‘caregiver’. However the current sample compared well 
with the majority of publications in the inclusion of spouse, family and friend caregivers as well as the 
amount of time spent caregiving.  
There was an under-representation of ethnic minorities in the current study. In the case of Māori 
and Pacific Islanders this may reflect reluctance to access healthcare including involvement in research 
(McPherson, Harwood, & McNaughton, 2003). Nonetheless, estimates by researcher Toni Pitcher 
(NZBRI) using recent Pharmac database prescription data, suggest the prevalence of PD in Māori is 
half that for non- Māori.  
The current sample was considered to be representative of other PD caregiving populations.  
4.2 Cognitive Status  
Caregiver Zarit Burden 
The main aim of the study was to investigate the influence of PD patient cognitive status on 
caregivers. Specifically, the cognitive status of the patients was assessed using recently published 
guidelines by the Movement Disorders Task Force thus describing the patients as PD-N, PD-MCI or 
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PD-D (Emre et al., 2007; Litvan et al., 2012). The primary outcome variable for caregivers was Zarit 
burden and mean burden scores increased significantly between caregivers in the three cognitive status 
groups: PD-D caregivers had significantly higher Zarit burden scores compared to both PD-N and PD-
MCI caregivers but carers of PD-MCI patients also showed increased burden scores relative to those 
of PD-N patients. No gender caregiver Zarit burden score differences were found and the significant 
effects of PD patient cognitive status remained after controlling for both PD patient motor problems 
and neuropsychiatric symptoms. The results highlight the progressive nature of caregiver burden in the 
context of worsening PD patient cognition and provide support for the description of PD-MCI as a 
clinical identity that has a significant impact. 
Previous research has reported conflicting results regarding the influence of cognitive status on 
caregiver burden, but this may be in part due to restricted outcome measures. For example when the 
Zarit burden instrument was employed, all three studies reported that PD patient cognition was 
associated with burden (Cifu et al., 2006; Leroi, McDonald, Pantula, & Harbishettar, 2012; Martinez-
Martin et al., 2008), a finding supported in the current research. However in studies using depression, 
distress or health measures as outcome instruments, no associations were found (Fernandez, Tabamo, 
David, & Friedman, 2001; Lee, McKeith, Mosimann, Ghosh-Nodyal, & Thomas, 2012; Meara, 
Mitchelmore, & Hobson, 1999; Miller, Berrios, & Politynska, 1996).  
The increase in Zarit burden scores between PD-N, PD-MCI and PD-D caregivers, was in 
contrast to the only other study to use MDS criteria to describe cognitive status in PD caregiving 
(Leroi, McDonald, Pantula, & Harbishettar, 2012). These authors reported differences between PD-N 
and PD-MCI versus PD-D but none between PD-N versus PD-MCI. PD-MCI caregivers in the current 
study experienced similar burden (mean Zarit burden = 20.65) to those in the Leroi study (mean Zarit 
burden= 23.61) but the PD-N and PD-D caregivers in the study by Leroi and colleagues were more 
burdened (mean Zarit burden=20.41 and 35.48 respectively), compared with those in the current study 
(mean Zarit burden=13.48 and 26.84 respectively). Perhaps the more comprehensive 
neuropsychological battery (20 tests) used in the current study provided greater diagnostic accuracy 
than the eight tests employed in the study by Leroi and colleagues (2012). Another explanation for the 
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contrary findings is different sample characteristics: PD-N mean neuropsychiatric inventory scores in 
the current study (3.4) were much lower than the mean neuropsychiatric inventory scores in the Leroi 
study (9.5) which in conjunction with cognitive deficits may have lead to greater caregiver burden 
amongst their PD-N caregivers.  
Forty one percent of caregivers in the current study scored ≥21 on the Zarit burden Interview 
indicating mild to severe burden (Zarit, Reever, & Bach-Peterson, 1980). While there was no 
information regarding the proportion of caregivers with Zarit burden scores ≥21 among other PD 
caregiving studies, reports from other caregiving studies have provided rates of 30% among muscular 
dystrophy caregivers (Boyer, Drame, Morrone, & Novella, 2006) and approximately 55% among 
caregivers of the elderly (Hebert, Bravo, & M, 2000). PD-MCI caregivers in the current study 
demonstrated higher rates of Zarit burden (58%) than the 30%-31.4% rates reported in Alzheimer’s 
studies of caregivers of patients with mild cognitive impairment (Bruce, McQuiggan, Williams, 
Westervelt, & Tremont, 2008; Hayashi et al., 2013; Springate & Tremont, 2012). The additional motor 
and neuropsychiatric symptoms of  
The current investigation used the Mini-Mental State Exam (MMSE) as part of the 
neuropsychological assessment to establish global mental status. The significant negative correlation 
found between all PD patients’ MMSE scores and negative caregiver outcome replicated the findings 
of Aarsland (1999), Cifu (2006) and Thommessen (2002) but were in contrast to those of D’Amelio 
(2009) and Fernandez (2001). Unlike the current, to establish PD-D two investigations used the 
Dementia Rating Scale (Table 1-1) to identify PD-D. The significant association between PD-D and 
caregiver burden was not replicated in these studies. Cifu and colleagues (2006) reported no 
association and in the other study, dementia status was associated with but not predictive of caregiver 
stress (Aarsland, Larsen, Karlsen, Lim, & Tandberg, 1999). The significant negative correlations 
between Montreal Cognitive Assessment (MoCA) scores (n=104), MMSE scores (n=67) and z scores 
(n=67) with Zarit burden in the current investigation further substantiated the influence of PD patient 
cognition on caregiver outcome. 
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Caregiver Depression and Anxiety 
There were no significant differences between caregiver depression scores across the three PD patient 
cognitive status groups. Contrary to the hypothesis that caregivers would respond to worsening PD 
patient cognition with reports of more depression symptoms, caregivers demonstrated fewer 
depression symptoms with worsening cognition (Figure 3-1b). This finding may reflect an acceptance 
over time to the diagnosis of PD and indicate positive adjustment in the caregiving role. Another 
explanation, in light of the negligible relationship between PD patient cognition and caregiver 
depression described earlier, is that Zarit burden identifies a unique contribution of distress in 
caregivers quite independent of depression. Another point of interest was the incidence of caregiver 
depression symptoms (7%), which were much lower than rates reported in other PD caregiving 
samples (34-64%) (Caap-Ahlgren & Dehlin, 2002; Meara, Mitchelmore, & Hobson, 1999) but similar 
to those reported in the general NZ population (6%; Ministry of Health, 2006). In two Alzheimer 
studies caregivers of patients with mild cognitive impairment rates of 12.5% (Blieszner & Roberto, 
2010) and 23% (Seeher, Low, Reppermund, & Brodaty, 2012) were provided. Again the low 
incidence of depression in the current sample may reflect acceptance and adjustment in the caregivers 
or may indicate poor applicability of the Geriatric Depression Scale in this sample of caregivers whose 
ages ranged from 23 to 83 years: The Geriatric Depression Scale was designed as an instrument for 
older populations.  
Caregiver anxiety symptoms also did not differ between caregivers in the three PD patient 
cognitive status groups and caregivers reported fewer anxiety symptoms with worsening cognition 
(Figure 3-1c). Again this finding may reflect acceptance and adjustment to the role of PD caregiving 
or highlight a unique contribution of Zarit burden quite independent of anxiety. Additionally, the 
Geriatric Anxiety Inventory was designed as an instrument for use in older populations and may 
therefore be unsuitable for use in the current sample with its wide range of ages. Rates of anxiety 
symptoms among caregivers in the current study (36%) were greater than that reported in the only 
other PD study investigating caregiver anxiety (21.7%) (Martinez-Martin et al., 2008) and greater than 
that reported in the general population (14.8%; Ministry of Health, 2006). Additionally, caregivers in 
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the current study expressed more symptoms of anxiety (36%) than Alzheimer’s caregivers (23.5%-
25%) (Cooper, Katona, Orrell, & Livingston, 2008; Mahoney, Regan, Katona, & Livingston, 2005). 
The additional neuropsychiatric and motor symptoms of PD appear to compound caregiver anxiety. 
Perhaps PD with its complex presentation creates increased anxiety among caregivers because of the 
need to maintain heightened vigilance related to potential threats in the environment for the PD 
patient.  
The incidence of depression symptoms (7%) among caregivers in the current study was similar 
to that reported by their respective PD patients (10%). Likewise, the incidence of anxiety symptoms 
among caregivers (36%) was also similar to that reported by the PD patients (35%) although there 
were a limited number of PD patient anxiety scores available (n=44). The low incidence of depression 
in caregivers in the current study may be the result of a low incidence of depression in the current PD 
patients’ which is also much lower than rates reported among their respective PD patients. The effect 
of a care recipient’s distress on caregivers has become a recent area of interest (Goodman & Shippy, 
2010): Early studies highlight an affect similarity or emotional contagion which may explain the 
almost identical incidence of depression and anxiety symptoms in the current PD patients and their 
caregivers. 
Caregiver Coping  
Caregivers responded to increasing burden with use of more total coping strategies but these 
differences were only large between PD-N versus PD-D patients; effect sizes were medium between 
PD-N versus PD-MCI patients and PD-MCI versus PD-D patients (Figure 3-2). The brief COPE 
instrument was subject to factor analysis and 3 dimension scores were derived, problem-focused, 
emotion-focused and dysfunctional coping (see Appendix D for a description of the factor analysis 
methods and results).  
There were significant positive correlations between all three types of coping and caregiver 
burden (Table 3-5). Hence the hypotheses that problem-focused and dysfunctional coping are 
associated with caregiver Zarit burden was supported and is consistent with the results from the study 
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of Alzheimer’s caregivers by Cooper and colleagues (2008). The only PD caregiving study to 
investigate coping (Sanders-Dewey, Mullins, & Chaney, 2001) and two further Alzheimer’s 
caregiving studies reported similar findings although a different instrument, the Ways of Coping 
Checklist was used and comparison is limited (Chou, LaMontagne, & Hepworth, 1999; Montoro-
Rodriguez & Gallagher-Thompson, 2009; Sanders-Dewey, Mullins, & Chaney, 2001). The findings 
are consistent with the theory by Lazarus which holds that attempts to change an unchangeable 
situation, such as the progressive debilitating disease of PD, will result in distress.  
With regard to emotion-focused coping the hypothesis that emotion-focused coping would 
protect caregivers from Zarit burden was not supported. While Sanders-Dewey and colleagues (2001) 
reported a positive association between emotion-focused coping and caregiver distress, in the Ways of 
Coping Checklist emotion-focused coping contains some items that are more similar to dysfunctional 
coping and so comparison is precluded. However the results of the current study are consistent with 
those from Cooper and colleagues (2008) who reported that emotional coping was adaptive. The 
finding that there were significant correlations between all three types of coping and caregiver burden 
in the current sample, may be of increased anxiousness: Caregivers therefore had an increased 
tendency to take proactive actions by using all three types of coping in an attempt to reduce their 
stress.  
Problem-focused coping was the only coping strategy to differ significantly between caregivers 
in the 3 patient cognitive status groups: PD-N caregivers used significantly less problem-focused 
coping strategies than PD–D and PD-MCI caregivers used significantly less problem-focused coping 
strategies than PD-D; there was no significant difference between PD-N and PD-MCI caregivers in 
problem-focused coping. The significant effect of patient cognitive status on Zarit burden remained 
after controlling for the effects of problem-focused, emotion-focused and dysfunctional coping which 
demonstrated that coping strategies were ineffective in reducing Zarit burden.  
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Patient Neuropsychiatric Symptoms 
Consistent with other studies investigating the impact of PD patient neuropsychiatric symptoms on 
caregivers (Aarsland et al., 2007; Leiknes, Tysnes, Aarsland, & Larsen, 2010), the current study found 
a significant association between Neuropsychiatric Inventory (NPI) ratings and caregiver Zarit burden. 
There was also a significant association between NPI ratings and cognitive status. This unexpected 
finding enabled further investigation with path analysis to investigate a possible mediating effect of 
neuropsychiatric symptoms between PD patient cognitive status and caregiver burden. A relationship 
between these variables was suggested by Aarsland and colleagues (2007). The authors identified an 
agitation cluster within the Neuropsychiatric Inventory and reported that patients in this cluster 
achieved significantly lower scores on the Mini-Mental State Exam than those in the other clusters.  
Time Spent Caregiving 
An unexpected finding in the current study was a significant difference in the number of hours spent 
caregiving between the three patient cognitive status groups. By definition, PD-MCI patients are not 
impaired in their ability to undertake activities of daily living but PD-MCI caregivers spent 
significantly more time engaged in providing care than PD-N caregivers. This implies that even in the 
early stages of the disease impaired cognition alone places additional demands on caregivers and 
provides support for the description of PD-MCI as a clinical identity that has a significant impact. 
4.3 Mediators of PD Patient Cognitive Status and Caregiving Zarit Burden 
Problem-focused coping was the only coping dimension that met the criteria for path analysis. 
Problem-focused coping mediated the relationship between PD patient cognitive status and caregiver 
Zarit burden. However, the inverse model with caregiver Zarit burden mediating the link between 
cognitive status and problem-focused coping was also significant therefore we cannot be confident 
about the directionality of this relationship to draw conclusions from the findings. Uncertainty over the 
directionality of this relationship was also reported in a previous investigation of caregivers of the 
elderly (Del-Pino-Casado, Frias-Osuna, Palomino-Moral, & Pancorbo-Hidalgo, 2011). In the current 
study we were unable to confirm whether problem-focused coping led to caregiver burden or whether 
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caregiver Zarit burden led to use of problem-focused coping. Perhaps in the early stages of PD 
caregivers employ problem-focused strategies which prove ineffective in reducing burden, and then 
overtime their increased burden leads to further problem-focused coping. Future studies which are 
longitudinal in design could better assess the temporal course of these events.  
Neuropsychiatric symptoms also mediated the relationship between PD patient cognitive status 
and caregiver Zarit burden. This finding suggested that caregivers of PD patients who reported more 
neuropsychiatric symptoms with lower cognitive ability were more likely to experience burden, and is 
consistent with the evidence from Aarsland and colleagues (Aarsland et al., 2007). Over and above the 
influence of neuropsychiatric symptoms however, PD cognitive status has the foremost influence on 
Zarit burden scores. Again longitudinal studies could better assess the influence of these individual 
factors over time. 
The hypothesis that Positive Attributions of Caregiving would mediate the relationship between 
PD patient cognitive status and caregiver Zarit burden was not upheld. Indeed there was no association 
between the Positive Attributions towards Caregiving Instrument and any of the caregiving outcome 
variables, but this may reflect its unsuitability with PD caregivers. The measure has previously been 
validated with Alzheimer’s dementia caregivers and may not have applicability in a sample of PD 
caregivers because of the heterogeneous symptoms associated with this disease. While some 
caregivers expressed strong positive feeling towards their role, others reported that the measure “did 
not capture their experience at all”. Since the positive feelings among some caregivers were 
undeniable, it could be that improved future instruments may identify the important construct of 
positivity that the Positive Attributions of Caregiving failed to recognize.  
4.4 “The Hardest Thing” 
The majority of caregivers of PD patients in the three cognitive status groups reported that the “hardest 
thing about providing care/support to someone with Parkinson’s disease” was the impact of reduced 
personal and social communication. Although this problem was most frequent in PD-D carer’s and did 
not seem to be influenced by PD-MCI status. Motor symptoms of PD were only the third most 
reported item. Patients’ abilities to communicate and relate to others have also been cited as causes of 
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caregiver burden and distress in previous general caregiving studies (Savundranayagam, Hummert, & 
Montgomery, 2005; Vitaliano, Russo, Young, Teri, & Maiuro, 1991).  
4.5 Limitations 
The caregivers and patients in the current study were already involved in other studies at the NZBRI 
including progression studies. This includes on-going neuropsychological assessment and scanning 
over several visits. The substantial time commitment by both patient and caregiver suggest that the 
sample in the current study were quite motivated and physically able individuals, which may influence 
measures such as anxiety and depression in these samples.  
Time constraints in the current investigation lead to fewer data being available for PD-D 
patients. Specifically, fewer than half the PD-D patients had current Unified Parkinson’s Disease 
Rating Scale scores which limited the description of the association between motor symptoms and 
caregiver burden.  
The current study was cross-sectional in design and therefore was limited it is ability to 
determine causality. However, the study’s strengths lie in the well-characterised PD patients who had 
undertaken comprehensive neuropsychological assessment to ensure robust cognitive status 
classification. Also the addition of the complementary qualitative question “What is the hardest thing 
about supporting/caring for someone with Parkinson’s disease?” provided further evidence of the 
significant impact of PD patients’ cognitive status on caregiver burden.  
4.6 Future Directions 
Longitudinal studies of PD patients would provide valuable information regarding those at greatest 
risk of progressing to PD-D. In light of the findings of the current study, which demonstrate that 
patient symptomology is associated with caregiver outcome, longitudinal investigations of PD 
caregivers may also add weight to this evidence as well as provide important insight into the changes 
overtime to the caregiving role in PD.  
Similarly, investigations of the neural correlates of cognitive impairment have provided 
excellent information regarding which patients are likely to convert from PD-MCI to PD-D. Studies of 
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the neural correlates of Zarit burden could support evidence from this research and provide 
information for caregivers to enable physical and emotional provision for disease progression. 
Specifically, patient quality of life has been shown to be associated with executive function and visuo-
spatial impairments and these too may be associated with caregiver burden. 
4.7 Concluding Remarks 
This research investigated the impact of PD patient cognitive status on caregiver burden. Previous 
studies have established that PD-D is associated with caregiver distress but the current investigation 
also found elevated levels of Zarit burden among PD-MCI caregivers, highlighting for the first time, 
the presence of Zarit burden prior to the onset of dementia. The unique experience of PD-MCI 
caregivers was further highlighted by the finding that PD-MCI caregivers spent significantly more 
time caregiving than PD-N caregivers but less than PD-D.  
In agreement with previous reports (Aarsland et al., 2007; Leiknes, Tysnes, Aarsland, & Larsen, 
2010), the current study found that cognitive symptoms and neuropsychiatric symptoms are 
contributors of negative outcomes for caregivers. There was however no associations between PD 
patient motor problems and caregiver Zarit burden, depression or anxiety.  
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6.1 Appendix A 
 
 
 
 
66 Stewart Street, Christchurch, New Zealand 
Telephone +64 3 378 6097 Fax +64 3 378 6080 
CONSENT FORM 
Supporting someone with Parkinson’s disease” 
I have read and understood the information sheet dated 1st November 2011for volunteers taking part in 
the study designed to gather data about supporting a person with Parkinson’s disease in people in 
Canterbury. I have had time to consider whether to take part. I have had the opportunity to discuss this 
study, and I am satisfied with the answers I have been given.  I have had the opportunity to use 
whanau (family) support or a friend to help me ask questions and understand the study. I further 
understand that taking part in this study is completely voluntary (my choice) and that I may withdraw 
from participation in this study at any time, and this will in no way affect my future health care. I 
understand that participation in this study is confidential and that no material which could identify me 
will be used in any reports of this study. I know who to contact if I have any questions or problems 
about the study. 
I consent to my GP being informed of my participation in this study………….………YES/NO 
         I wish to receive a copy of the results………………………………………………..…YES/NO  
         Name of GP……………………………………………………………………………………….. 
I consent to the information gathered about me being used for future research into studies related to 
Parkinson’s disease (subject to ethical approval being given by a New Zealand  
Accredited  ethics committee)……………………………...…..……….……………....YES/NO 
I wish to be part of the Van der Veer Institute’s volunteer database…………..……….YES/NO  
I consent to the use of my data for future related studies, which have been given ethical approval from 
a Health & Disability Ethics 
Committee…………………………………………………………YES/NO 
I      (full name) hereby consent to take part in this study, and 
understand that by agreeing to be part of a volunteer database that I could be contacted again for another 
research study.  I also understand that if I am contacted again, that I do not have to participate in that 
study.  
 
Signature of Participant                                       
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Signature of witness 
 
Project explained by 
 
The following is the 2001 census form question about ethnicity. This data is collected for study 
demographics only 
 
 
 
Researchers:  
Ann Jones, Associate Professor John Dalrymple-Alford, Roeline Kuijer, Leslie Livingston, Professor 
Tim Anderson  
 
Phone: 3786346 ext 86346 (Ann Jones – Masters Student) 
Email: anniejones@xtra.co.nz 
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Principal Investigator  
 Ann Jones 
               Masters Student 
               University of Canterbury 
               New Zealand Brain Research Institute 
               66 Stewart Street, 
               Christchurch, 8011. 
               Phone 3786346 ext 86346  
               Mobile 0276542299 
 
 
 
 
 
 
 
 
 
 
You are invited to participate in a study that will look at supporting someone with Parkinson’s disease. This 
study will be undertaken to fulfill the requirements for the degree of Master of Arts at the University of 
Canterbury. You would respond to five brief questionnaires, which will take approximately 60 minutes. By 
taking part in the study you will help us detect the factors that influence outcomes for support people in the 
context of Parkinson’s disease. We hope that the information we gather may help clinicians improve the 
quality of life for both support people and those with Parkinson’s disease. You do not have to take part in the 
research if you prefer not to. You may withdraw at any time. With your permission, data from this study may 
be used in future related studies, which have been given ethical approval from a Health & Disability Ethics 
Committee. 
 
1. Aim of the study 
       To investigate your experience as a support person for someone with Parkinson’s disease.  
 
2.    Participants 
       People who are family members or friends of someone with Parkinson’s disease are welcome  
       to participate: They may or may not be living with the person, but need to be directly   
       involved with the person. One hundred people who support a person with Parkinson’s disease will  
       take part in the study. 
 
 
 
Supervisors of the study (cont) 
 Roeline Kuijer, 
               Senior Lecturer, 
               Department of Psychology, 
               University of Canterbury, 
               Christchurch. 
               Phone 3642987 ext3401 
 
 Tim Anderson 
Professor of Neurology 
University of Otago 
               New Zealand Brain Research Institute 
               66 Stewart Street, 
               Christchurch, 8011. 
               Phone 37860798  
Supervisors of the study 
 John Dalrymple-Alford 
Associate Professor in Psychology  
University of Canterbury, 
               New Zealand Brain Research Institute 
               66 Stewart Street, 
               Christchurch, 8011. 
Phone 3642998 ext 6998 
 
Invitation to join the study 
 
“Supporting someone with Parkinson’s disease” 
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3.    Your involvement 
Your involvement is voluntary and you can withdraw from the study at any time without giving a 
reason. There will be no disadvantage to you. Your name and personal details are strictly confidential 
and will not be mentioned in the final report. If you decide to participate you will be asked to sign a 
consent form to confirm your willingness to take part in the study. 
   
4.    Interview location  
       The interview will be carried out either at the Van der Veer Institute or in your home. You will      
       be reimbursed with petrol vouchers should you choose to be interviewed at the Van der      
       Veer Institute. A family member (whanau) or support person is welcome to be present during the  
       interview. 
 
5.    Interview Content 
       There will be one meeting to collect information for the study. We will ask you questions about    
        your role in providing support to your family member or friend with Parkinson’s disease. Any   
       participants who find that some questions raise negative emotions or memories may be directed to  
       the appropriate services: The Multiple Sclerosis and Parkinson's Society of Canterbury, GP  
       and/or Caring for Carers. Brochures with relevant telephone numbers will be available if  
       requested. If clinically significant information is identified during the interview, consent  
       will be sought to inform the participants G.P. 
 
6.    Study Information Storage. 
       Every participant and the person with Parkinson’s disease for whom support/care is provided, will  
       be identified with a study number (no names are used). All information will be kept at the Van der  
       Veer Institute. Only the study researchers have access to the information. Documents will be stored  
       in a locked filing cabinet at the Van der Veer Institute. Data will be stored on the researcher’s  
       password protected computer. At the end of the study the data will be kept securely for 10 years  
       after which time it will be destroyed.  
 
7.    Risks of the study. 
       There are no risks to you as a participant.  The benefit of the study is that your experiences and  
       opinion of coping with someone with Parkinson’s disease may be beneficial to others in the same  
       situation.  
 
8.    Concerns during the study  
       If you have any queries or concerns regarding your rights as a participant in this study you can    
       contact the Health and Disability Advocate : 0800377766 or (03)3777501. 
 
9.    Results 
       It is expected that the final written report will be completed by the end of 2012. If you wish, a    
       summary of the findings will be posted to you.  
 
10.  Ethics 
       This study has been given ethical approval by the Upper South A Regional Ethics Committee. 
       Thank-you for considering to take part in this study. 
       Principal researcher:  Annie Jones e-mail: anniejones@xtra.co.nz   
                                          phone: 3786346 ext86346 or 0276542299  
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6.2 Appendix B  
 
Significant Other/Caregiver Measures: For carers of PD Patients with Brief Cognitive 
Assessment 
The Activities of Daily living – International Scale  
The Activities of Daily living – International scale (ADL-IS; (Reisburg et al., 2001) consists of 40 
questions such as “Does the [patient/subject] have difficulty putting household items in the right 
places?” to which the informant is asked to respond using a Likert scale of 0 = ‘never has difficulty’ to 
3 = ‘always has difficulty’. A response of 4 = ‘activity no longer performed (ie. has given up initiating 
the activity)’; 8 = ‘activity was never performed’ and 9 = ‘unknown’.  
The Neuropsychiatric Inventory  
The Neuropsychiatric Inventory (NPI;(Cummings et al., 1994) is structured interview of the 
significant other/caregiver used to identify possible behavioural symptoms associated with Parkinson’s 
disease. Items assessed are: delusions, hallucinations, agitation/aggression, depression, anxiety, 
elation/euphoria, apathy/indifference, disinhibition, irritability/liability, aberrant motor behaviour, 
night-time behaviour and appetite/eating change. For each question, the informant is asked to rate the 
frequency (1 = ‘occasionally, less than once per week,’ 4 = ‘very frequently – essentially continuously 
present’), severity (1 = ‘mild, depression is distressing but usually responds to redirection or 
reassurance,’ 3 =’ marked – depression is very distressing and a major source of suffering for the 
patient’) and distress of the patients behaviour (0 = ‘not at all’ to 5 = ‘very severely or extremely’). 
Parkinson’s disease Patient Measures: For PD patients who had Brief Cognitive Assessment. 
Verbal Fluency (letter) 
The Verbal Fluency test (Delis, Kaplan, & Kramer, 2001) is sensitive to the executive impairments 
seen in patients with PD. Participants are instructed to say as many words as they can that begin with a 
certain letter of the alphabet (F, A, or S), but not names, numbers, or places, or the same word with a 
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different ending. Scores are obtained from the number of correct words produced from verbal 
responses within 1 minute.  
Action Fluency 
The Action Fluency task is also a measure of executive function. Patients are instructed to say as many 
action words they can. The words may start with any letter and should describe things that people do 
(action words). Scores are taken from verbal responses and the number of correct action words 
produced within 1 minute.  
Months Reversed 
The months reversed task assesses elective attention and mental control. Participants are asked to state 
the months of the year backwards, beginning at December. Scoring cut-off is the omission of 2 or 
more months or failure to complete the test within 90 seconds (Dubois et al., 2007). 
 
The Mini Mental State Examination 
The Mini Mental Status Examination (MMSE) is a screening test designed to assess general cognitive 
status (Molloy & Standish, 1997). The MMSE consists of 30 questions with one point for each correct 
answer. The areas of cognitive functioning assessed are: orientation, registration, attention, working 
memory, recall, language, and construction.  
 
The Montreal Cognitive Assessment  
The Montreal Cognitive Assessment (MoCA) (Nasreddine et al., 2005) is a measure of general 
cognitive status. The MoCA consists of 8 components designed to measure general skills of attention 
and concentration, executive functions, memory, language, visuo-constructional skills, conceptual 
thinking, calculation, and orientation. The MoCA is scored out of 30 and is more sensitive to mild 
cognitive impairment than the MMSE in PD (Mamikonyan et al., 2009) (Dalrymple-Alford et al., 
2010)   
62 
 
Parkinson’s disease Patient Measures: For PD patients who had Full Cognitive Assessment 
The patients were classified as either showing normal cognition (PD-N), with mild cognitive 
impairment (PD-MCI) or with dementia (PD-D) on the basis of neuropsychological testing 
(Dalrymple-Alford et al., 2011). Dementia classification was based on the Movement Disorders 
Society Task Force criteria (Emre et al., 2007). Mild cognitive impairment cases were defined as 
having generally intact functional activities of daily living but scores 1.5SDs or more below normative 
data on at least two measures within at least one of four cognitive domains: executive function: letter 
fluency; action fluency; category fluency; category switching;(Stroop, 1935) Stroop (Delis, Kaplan, & 
Kramer, 2001) Trails B (Reitan, 1958); attention, working memory and processing speed: digits 
forward and backwards, digit ordering (Kaplan, Fein, Morris, & Delis, 1991); map search (Robertson, 
Ward, Ridgeway, & Nimmo-Smith, 1996); Stroop-colour-naming and Stroop-word-reading; (Delis, 
Kaplan, & Kramer, 2001) Trails A (Reitan, 1958); learning and memory: California Verbal Learning 
Test-free recall (Elwood, 1995); California Verbal Learning Test Short Delay; Rey Complex Figure 
recall (Osterrieth, 1944); and visuoperceptual and visuospatial skills Rey Complex Figure copy 
(Osterrieth, 1944), Judgement Orientation (Benton, Varney, & Hamsher, 1978); fragmented letters 
(Warrington & James, 1991); PD-N patients do not meet the criteria for MCI. Global cognitive status 
was measured with the Mini Mental State Examination (Molloy & Standish, 1997) and the Montreal 
Cognitive Assessment (MoCA; (Nasreddine et al., 2005)). The Geriatric Depression Scale (GDS-15; 
(Weintraub, Oehlberg, Katz, & Stern, 2006) was also used to assess the PD patients. 
 
 
 
 
 
 
 
 
63 
 
6.3 Appendix C 
C-1 The Zarit Burden Interview 
  
Please circle the response the 
best describes how you feel. 
Never  
Rarely  Sometimes  Quite Frequently  Nearly Always  Score  
1. Do you feel that your relative 
asks for more help than he/she 
needs?  
0  1  2  3  4  
2. Do you feel that because of 
the time you spend with your 
relative that you don’t have 
enough time for yourself?  
0  1  2  3  4  
3. Do you feel stressed 
between caring for your relative 
and trying to meet other 
responsibilities for your family 
or work?  
0  1  2  3  4  
4. Do you feel embarrassed 
over your relative’s behaviour?  
0  1  2  3  4  
5. Do you feel angry when you 
are around your relative?  
0  1  2  3  4  
6. Do you feel that your relative 
currently affects our 
relationships with other family 
members or friends in a 
negative way?  
0  1  2  3  4  
7. Are you afraid what the 
future holds for your relative?  
0  1  2  3  4  
8. Do you feel your relative is 
dependent on you?  
0  1  2  3  4  
9. Do you feel strained when 
you are around your relative?  
0  1  2  3  4  
10. Do you feel your health has 
suffered because of your 
involvement with your relative?  
0  1  2  3  4  
11. Do you feel that you don’t 
have as much privacy as you 
would like because of your 
relative?  
0  1  2  3  4  
12. Do you feel that your social 
life has suffered because you 
are caring for your relative?  
0  1  2  3  4  
13. Do you feel uncomfortable 
about having friends over 
because of your relative?  
0  1  2  3  4  
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14. Do you feel that your 
relative seems to expect 
you to take care of 
him/her as if you were 
the only one he/she 
could depend on?  
0  1  2  3  4  
15. Do you feel that you 
don’t have enough 
money to take care of 
your relative in addition 
to the rest of your 
expenses?  
0  1  2  3  4  
16. Do you feel that you 
will be unable to take 
care of your relative 
much longer?  
0  1  2  3  4  
17. Do you feel you have 
lost control of your life 
since your relative’s 
illness?  
0  1  2  3  4  
18. Do you wish you 
could leave the care of 
your relative to someone 
else?  
0  1  2  3  4  
19. Do you feel uncertain 
about what to do about 
your relative?  
0  1  2  3  4  
20. Do you feel you 
should be doing more for 
your relative?  
0  1  2  3  4  
21. Do you feel you 
could do a better job in 
caring for your relative?  
0  1  2  3  4  
22. Overall, how 
burdened do you feel in 
caring for your relative?  
0  1  2  3  4  
Total Score (out of 88)  
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C-2 The Brief COPE 
Brief Coping Orientations for Problems Experienced (COPE).    
These items deal with ways you've been coping with supporting someone with Parkinson’s disease.  
There are many ways to try to deal with this role.  These items ask what you've been doing to cope 
with your situation.  Obviously, people deal with things in different ways, but I'm interested in how 
you've tried to deal with it.  Each item says something about a particular way of coping.  I want to 
know to what extent you've been doing what the item says: How much or how frequently.  Don't 
answer on the basis of whether it seems to be working or not—just whether or not you're doing it.  Use 
these response choices.  Try to rate each item separately in your mind from the others.  Make your 
answers as true FOR YOU as you can.  
 
1 = I haven't been doing this at all  
2 = I've been doing this a little bit  
3= I’ve been doing this a medium amount 
4= I’ve been doing this a lot 
 1 2 3 4 
1.  I've been turning to work or other activities to take my mind off things     
2.  I've been concentrating my efforts on doing something about the situation I'm in     
3.  I've been saying to myself "this isn't real."     
4.  I've been using alcohol or other drugs to make myself feel better     
5.  I've been getting emotional support from others     
6.  I've been giving up trying to deal with it     
7.  I've been taking action to try to make the situation better     
8.  I've been refusing to believe that it has happened     
9.  I've been saying things to let my unpleasant feelings escape     
10.  I’ve been getting help and advice from other people     
11.  I've been using alcohol or other drugs to help me get through it     
12.  I've been trying to see it in a different light, to make it seem more positive     
13.  I’ve been criticizing myself     
14.  I've been trying to come up with a strategy about what to do     
15.  I've been getting comfort and understanding from someone     
16.  I've been giving up the attempt to cope     
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1 = I haven't been doing this at all  
            2 = I've been doing this a little bit 
3= I’ve been doing this a medium amount 
4= I’ve been doing this a lot 
 1 2 3 4 
17.  I've been looking for something good in what is happening     
18.  I've been making jokes about it     
19.  I've been doing something to think about it less, such as going to movies,      
watching TV, reading, daydreaming, sleeping, or shopping 
 
    
20.  I've been accepting the reality of the fact that it has happened     
21.  I've been expressing my negative feelings     
22.  I've been trying to find comfort in my religion or spiritual beliefs     
23.  I’ve been trying to get advice or help from other people about what to do     
24.  I've been learning to live with it     
25.  I've been thinking hard about what steps to take     
26.  I’ve been blaming myself for things that happened     
27.  I've been praying or meditating     
28. I’ve been making fun of the situation     
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C-3 The Positive Aspects of Caregiving Scale 
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C-4 The Geriatric Depression Scale 
 
Older Person’s Mood Scale (GDS): Brief 15-item version. 
Present Qs verbally, circling answer but do not show participant. 
Say, “Please choose the best answer for how you have felt over the past week.” 
If necessary, repeat the question; get clear Yes/No (more yes or more no).  
(circle all responses; count bold) 
    
1. Are you basically satisfied with your life?                                         Yes   No 
 
2. Have you dropped many of your activities and interests?           Yes    No 
 
3. Do you feel happy most of the time?                                    Yes   No 
 
4. Do you prefer to stay at home rather than going out and doing new things?   Yes    No 
If none of the above responses suggests depressive mood, STOP HERE.  
 
If any bolded responses above (suggests depression) ask questions 5-15. 
 
5. Do you feel that life is empty?                         Yes    No 
 
6. Do you often get bored?                                      Yes    No 
 
7. Are you in good spirits most of the time?                                   Yes   No 
 
8. Are you afraid that something bad is going to happen to you?                   Yes    No 
 
9. Do you often feel helpless?                                    Yes    No 
 
10. Do you feel that you have more problems with memory than most?            Yes    No 
 
11. Do you think it is wonderful to be alive?                                 Yes   No 
 
12. Do you feel pretty worthless the way you are now?                      Yes    No 
 
13. Do you feel full of energy?                                     Yes   No 
 
14. Do you feel that your situation is hopeless?                                   Yes    No 
 
15. Do you think that most people are better off than you are?                          Yes    No 
 
CHECK: Was Q12 Yes or No (circle)   GDS SCORE:   
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C-5 The Geriatric Anxiety Inventory 
GAI-SF: Please answer the items according to how you’ve felt in the last week. 
 
Tick the circle under Agree if you mostly agree that the item describes you.  
Tick the circle under Disagree if you mostly disagree that the item describes you. 
 
 
Agree Disagree 
1 I worry a lot of the time. O O 
2 Little things bother me a lot. O O 
3 I think of myself as a worrier. O O 
4 I often feel nervous. O O 
5 My own thoughts often make me anxious. O O 
As before, please answer the items according to how you’ve felt in the last 
week. 
 
Agree Disagree 
I find it difficult to make a decision. O O 
I often feel jumpy. O O 
I find it hard to relax. O O 
I often cannot enjoy things because of my worries. O O 
I often feel like I have butterflies in my stomach. O O 
I can’t help worrying about even trivial things. O O 
I get an upset stomach due to my worrying. O O 
I think of myself as a nervous person. O O 
I always anticipate the worst will happen. O O 
I often feel shaky inside. O O 
I think that my worries interfere with my life. O O 
My worries often overwhelm me. O O 
I sometimes feel a great knot in my stomach. O O 
I miss out on things because I worry too much. O O 
I often feel upset. O O 
70 
 
6.4 Appendix D 
Factor Analysis of the Brief COPE. 
Non-metric Multidimensional Scaling (MDS) using Guttman’s Smallest Space Analysis (SSA) was 
used to gain a visual impression of the structural patterns and item clusters in the data of the Brief 
COPE. The input matrix of item similarities was generated using a Euclidian distance coefficient 
(Barrett, Hogan, & Hogan, 2009) which is a Euclidean distance index expressed as a proportion of the 
maximum-possible distance between objects, given a fixed measurement range for every object. 
Similarity ranges from 0 (identical magnitudes) through to 1, which represent the maximum stress 
value of 0.09 for a 2 dimensional solution, which is considered satisfactory according to criteria set by 
Young (1985). The graphical representation of the double scaled Euclidian distance transformations 
confirmed that the Brief COPE data from the current sample were not unidimensional and identified 
that some items pairs were not homogenous (Figure 6-1).  
 
Figure 6-1. Non-metric MDS (SSA) solution for the subscale items of the Brief COPE questionnaire.  
 
Following the SSA, principal components analyis with varimax rotation was undertaken to 
identify possible clusters among the individal items of the Brief COPE. The number of factors with 
eigenvalues greater than 1 (Kaiser, 1960) and the results of the scree test (Cattell, 1966) suggested that 
a 3 factor solution was optimal although previously published literature has used 9, 3 and 2 factor 
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solutions for the brief COPE (Carver, Scheier, & Weintraub, 1989; Cooper, Katona, Orrell, & 
Livingston, 2008; Snell, Siegert, Hay-Smith, & Surgenor).  
In order to examine whether the current data could be rotated into maximal congruity with the 
previously published COPE target factor matrix (rather than solely to simple structure via the Varimax 
criterion), an orthogonal procrustes solution (Schonemann, 1968) was implemented using the 
Orthosim program (Barrett, 2006). This procedure transforms each matrix (the target and comparison 
matrix) to an orthogonalized form (if both or either is an obliquely rotated matrix) prior to rotating the 
orthogonalized comparison matrix to the orthogonalized target matrix, utilizing a least-squares 
criterion to establish the optimal fit between the two matrices. The procedure reports the ‘target-
comparison’ fit as a series of conguruence coefficients between each respective component factor from 
both matrices. The procedure also reports a ‘mean solution congruence’ which is the average 
congruence computed across all Brief COPE items, where each target item vector (factor) is compared 
to its counterpart in the comparison matrix. An orthogonal procrustes solution presupposes an 
orthogonal target matrix; two previously published studies provided evidence that the Brief COPE was 
characterized by an orthogonal 3-factor solution (Coolidge, Segal, Hook, & Stewart, 2000; Cooper, 
Katona, Orrell, & Livingston, 2008) 
The 3 factor solution for the brief COPE used as the target matrix describes problem-focused, 
emotion-focused and dysfunctional coping dimenstions (Coolidge, Segal, Hook, & Stewart, 2000; 
Cooper, Katona, Orrell, & Livingston, 2008). Comparisons were made between the target and the 
current data matrices to assess whether data from the current study was congruent with the target 
matrix. The congruence coeffiecnts between the targe matrix and the data from the curent study matrix 
roatated into maximal congruity via the procrustes procedure are shown in Table 6-1.  
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Table 6-1. Congruence coefficients and component-factor loadings from the maximally congruent orthogonal 
procrustes solution derived from a Principal Components factor analysis of the Brief COPE in a sample of PD 
patient caregivers (n=104). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The recommended factor loading level of >.4 (Gorsuch, 1983) was achieved by all but the 
denial and self-blame subscales and one item from the positive reframing subscale. Items loading on to 
factor 1 included the self-distraction, substance use, behavioural disengagement and venting subscale 
items from the dysfunctional dimension. Items loading onto factor 2 included the religion, acceptance 
and humour subscales and one items from the positive reframing subscale which formed the emotion-
focused dimension. The emotional support subscale loaded more strongly to items from factor 3, the 
problem-focused subscale. It was felt that seeking emotional support could sit well in a dimension 
associated with finding solutions, therefore it remained in that dimension along with active coping, 
 Factor 1 Factor 2 Factor 3 
 (Dysfunctional ) (Emotion-focused) (Problem-focused) 
Congruence coefficient .76* .67* .84* 
Self-Distraction 1 .62 -.06 .41 
Self- Distraction 2 .51 -.06 .35 
Denial 1 .25 .30 -.01 
Denial 2 .32 .26 -.22 
Substance Use 1 .64 -.35 .12 
Substance Use 2 .60 -.17 .01 
Behavioural Disengagement 1 .61 .06 -.08 
Behavioural Disengagement 2 .55 .16 -.06 
Venting 1 .56 .17 .22 
Venting 2 .60 .44 .06 
Self Blame 1 .37 .16 .20 
Self Blame 2 .09 .25 -.04 
Emotional Support 1 .18 .18 .69 
Emotional Support 2 .12 .25 .64 
Positive Reframing 1 -.02 .20 .31 
Positive Reframing 2 .22 .64 .07 
Humour 1 .05 .66 -.06 
Humour 2 .14 .55 -.11 
Acceptance 1 .03 .41 .22 
Acceptance 2 .03 .59 .24 
Religion 1 .21 .50 -.04 
Religion 2 .21 .51 -.04 
Active Coping1 .30 .10 .57 
Active Coping2 .33 .22 .66 
Instrumental Support1 -.06 .23 .74 
Instrumental Support2 -.06 .54 .56 
Planning 1 .23 .33 .52 
Planning 2 .19 .52 .49 
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seeking instrumental support and planning subscale items. The overall solution congruence of .79 fell 
only just below the acceptable criterion of.8 (Streiner, 2003). The congruence coefficients between the 
corresponding target and input matrix component fators are provided in the first row of Figure 6-1 and 
are slightly below the preferred criterion but were also considered acceptable for research purposes 
(Streiner, 2003).  
Internal Consistency 
The Cronbach coefficient α was calculated for each of Carver’s original subscale item pairings. All 
items pairs except positive reframing (.21) and denial (.49) exceeded Carver’s criterion of .5, although 
self-blame(.57)  and behavioural disengagement (.56) failed to reach the conventionally accepted 
criterion of .7 (Streiner, 2003).  
 
1. Active Coping  α = .76  I’ve been concentrating my efforts on doing something about the situation I’m in. 
 I’ve been taking action to try to make the situation better. 
2. Emotional Support  α = .81  I’ve been getting emotional support from others.  
 I’ve been getting comfort and understanding from someone. 
3. Instrumental Support  α = .76  I’ve been getting help and advice from other people. 
 I’ve been trying to get advice or help from other people about what to do. 
4. Planning  α = .70  I’ve been trying to come up with a strategy about what to do. 
 I’ve been thinking hard about what steps to take. 
5. Humour  α= .79  I’ve been making jokes about it. 
 I’ve been making fun of the situation. 
6. Venting  α = .72  I’ve been saying things to let my unpleasant feelings escape. 
 I’ve been expressing my negative feelings. 
7. Acceptance  α = .70  I’ve been accepting the reality of the fact that it has happened. 
 I’ve been learning to live with it. 
8. Positive Reframing  α= .21  I’ve been trying to see it in a different light, to make it seem more positive. 
 I’ve been looking for something good in what is happening. 
9. Religion  α= .89  I’ve been trying to find comfort in my religion or spiritual beliefs. 
 I’ve been praying or meditating. 
10. Substance Use  α= .76  I’ve been using alcohol or other drugs to help me get through it.    
   I’ve been using alcohol or other drugs to help me get through it.    
11. Behavioural 
Disengagement  
α= .56  I’ve been giving up trying to deal with it. 
 I’ve been giving up the attempt to cope 
12. Denial  α = .49  I’ve been saying to myself “this isn’t real”. 
 I’ve been refusing to believe that it has happened. 
13. Self-Blame α = .57  I’ve been criticizing myself. 
 I’ve been blaming myself for things that happened. 
14. Self-Distraction  α = .84  I’ve been turning to work or other activities to take my mind off things. 
 I’ve been doing something to think about it less, such as going to movies, watching 
TV, reading, daydreaming, sleeping or shopping. 
 
